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ABSTRACT: 
Phthalates are industrial chemicals widely used in consumer products including 
cosmetics, building material and medical equipment made with polyvinyl chloride (PVC) 
plastics and children toys, and the risk of exposure to phthalates is increasing continuously.  In 
recent years many studies have been carried out on the possible health hazards of phthalates, 
including the effect on reproduction. However, there is still an inconsistency of teratological 
information on phthalates. Therefore we used the Chick Model, which provide a suitable 
model for the rapid evaluation of phthalates behavioral teratogenicity, and enable rapid 
screening for potential developmental disruptors by avoiding maternal toxicity, maternal-fetal 
unit and maternal-neonatal interactions. 
  Pre hatching exposure of chicks embryo to di(2-ethyl hexyl) phthalates DEHP in doses 
ranging from 20 – 100 mg / kg, have reduced percentage hatching from 80% in control eggs to 
65%, and increased late hatching from 12.5 % in control eggs to 29.4 %. In addition it induced 
developmental defects characterized by a hole or weakening of abdominal muscles allowing 
internal organs to protrude externally with or without a sac (Omphalocele) or (Gastroschisis). 
The effect was dose dependent starting from 8% with DEHP (20 mg/kg) to 22 % with DEHP 
(100 mg/kg). Similar treatment with Di-butyl phthalates (DBP) 100 mg/kg has reduced 
percentage hatching to 57 % and increased late hatching to 37.5 %, with 14 % increase in 
developmental defects characterized as Gastroschesis.  
Neurobehavioral measurements using imprinting test and locomotor activity on chicks, 
pretreated with DEHP 50-100 mg/kg,  has shown a significant reduction of 21.6 % in 
imprinting performance which indicated neurobehavioral teratogenic activity.   
DNA damage measurements using ELISA kit which measures the blood concentration 
of the metabolite 8-hydroxydeoxyguanosine (8-OH-dG), has shown a trend of increase by 
39.7% following pre exposure to phthalates, which was significant with DEHP, indicating 
genetic toxicity of phthalates on embryonic development. 
VIII 
In Female Rats Model where the rats were injected twice weekly with DBP or DEHP 
(100 mg/kg) and cohabited with male rats for one month, we found a significant effects of 
DBP and DEHP on female fertility, by decreasing fertility rate from 87 % in control rats to 67 
% and 50 % respectively and by increasing mortality rate in new born litters from 2.8 % to 
52.3 % and 31.3 % respectively. Fecundity rate which express the average number of litters in 
each delivery was reduced from 8.2 in control treated rats to 7.3 in DBP treated and to 5.3 in 
DEHP treated rats.  
No significant changes were observed in total body weight gain, or with the relative 
weight of the following organs, heart, spleen, liver, or brain. The only significant changes in 
relative weight were detected following treatment with DBP (100 mg/kg) , 27.5 % decrease in 
female sex organs (P ≤ 0.05), and significant reduction of 7 % in kidneys. The change in 
female rats fertility following continuous treatment with DBP (100 mg/kg) were accompanied 
with a significant increase of 29.8% in blood serum 8-hydroxydeoxyguanosine (8-OH-dG), 
which is considered as a marker for DNA oxidative stress.  
As biochemical changes in blood of female rats are concerned, phthalates induced a 
significant increase in GPT and GOT, and a significant reduction in alkaline phosphatase, uric 
acid and creatinine, which indicates a drug related injury to hepatic cells. No changes were 
observed in glucose, triglycerides, total protein, total cholesterol, HDL, and LDL. 
In conclusion, our results provide evidence about the teratogenic activity of phthalates on 
chick embryonic development. Phthalates caused a significant decrease in egg hatching 
percentage and increasing late hatching and it also induced Gastroschisis and Omphalocele in 
22% of the cases. The decrease in imprinting performance indicates neurobehavioral 
teratogenic activity.  Part of the teratogenic activity is associated with oxidative stress and 
DNA damage. The elevated levels of alkaline phosphatase is due to a bony pathology or 
muscular dystrophy, which in turn might reduce muscle dry mass leading to decrease in 
creatinine and urea. 
 
IX 
On female rat’s fertility, Phthalates has decreased fertility rate, fecundity rate and 
increased mortality rate in new born litters, associated with significant reduction in relative 
weight of female sex organs, and increase DNA damage following treatment with DBP. 
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 :ملخص
 " ةالأجن تطور مراحل و خصوبةال على الفثالات مرآبات تأثير "
  
  التجميلية المستحضرات ذلك في بما ,المستهلك منتجات في آبير  بشكل تستعمل صناعية مواد هي الفثالات
 للفثالات رضالتع خطر أن آما ,الأطفال ألعاب أيضا و بلاستيك    CVP   من المصنوعة الطبية المعداتو  البناء ومواد
  .رباستمرا يزداد
 على التأثير ذلك في بما فثالاتلل الصحية المخاطر في للبحث عديدة دراسات أجريت ,الأخيرة السنوات في
 استخدمنا لذلك و .الأجنة بتشوه الفثالات علاقة عن المعلومات في تناقض هناك زال ما ,لكن .الجنين تطور و التناسل
 لإمكانية ريعس فحص يقدم و ,الأجنة تشوه في الفثالات تأثيرل السريع مللتقيي مناسب موذجن يقدم الذي ,الصيصان نموذج
  .الأم عن الناتجة السمية تأثير تجنب طريق عن التطور في اختلال
 زداداو ,%56 إلى  %08 من التفقيس  نسبة فانخفضت (.آغم\ ملغم001-02)   PHED مادة حقن تم الفقس قبل   
 أو ثقب بوجود تتميز الجنيني التطور في عيوب تظهر ذلك إلى بالإضافة %.4.92 إلى  %5.21 نم المتأخر التفقيس
 و الامنيوسي فتقال تسمى آيس بدون أو مع للخارج  الداخلية الأعضاءو الأمعاء تبرز بحيث البطن بعضلات ضعف
 بترآيز  PHED  استخدام  مع %8 من لاتالفثا ترآيز و التأثير بين طردية علاقة هناك آان . التوالي على المعوي الفتق
 نسبة انخفض (آغم\مغم 001) PBD مادة حقن وعند  .(آغم\مغم 001)  PHED  استعمال مع %22 إلى (آغم\مغم 02)
 مثل التطور في عيوب ظهور في %41 بقيمة زيادة لىإ أدى آما ,%5.37 إلى المتأخر التفقيس ادوز  %75 إلى التفقيس
   .المعدي الفتق
  مادةب العلاج بعد الصيصان على  الحرآي النشاط و العصبي السلوك فحص تم GITNIRPMI  اختبار تخدامباس
 بنشاط تشوهات وجود على دلي مما ختبارلابا %5.12 قيمةب واضح انخفاض لىإ أدى فقد ,(آغم\مغم001-05) PHED
  .العصبي السلوك
 أدى .الدم في  )Gd-HO-8( ترآيز تقيس التي و   YASSA ASILE  باستخدام النووي الحمض تلف قياس تم
 تشير والتي ,   PHED مادة استعمال مع ملحوظا آان الذيو للفثالات التعرض بعد  )Gd-HO-8( مادة ترآيز ارتفاع لىإ
 .الجنيني التطور مرحلة في للفثالات جينية سمية إلى
  IX
  PBD  اوPHED  بمادة أسبوعيا تينمر حقنهم تم حيث الفئران ناثإ على الفثالات تأثير دراسة عندو
 عن الإناث خصوبة على PBD ,PHED  لمادتينل ملحوظ تأثير ظهر ,واحد شهر لمدة الذآور مع عاشوا و (مغآ\مغم001)
 عند  الوفيات معدل زيادة طريق عنو ,التوالي على %05و %76 إلى %78 من الخصوبة معدل من التقليل طريق
 الفئران عدد متوسط عن يعبر الذي و) الإخصاب معدل .التوالي على %3.13 و %3.25 إلى %8.2 من الولادة حديثي
 حالة فى %3.5 و  PBD استخدام عند %3.7 إلى %2.8 من الإخصاب معدل انخفض ,(لهم ولادة آل عند الولادة حديثي
  .     PHED مادة استخدام
 ,البنكرياس ,القلب ,التالية عضاءللأ النسبي نلوزل بالنسبة أو ,لجسمل الكلي وزنال زيادةب تغير أي يلاحظ لم
 وزن ضاانخفب ذلك وتجسد ,(آغم\مغم001) PBD مادةب العلاج بعد ملحوظ ريتغي على حصلنا لقد . الدماغو دالكب
  .كليةلل النسبي وزنبال %7 بنسبة خفاضانو  ,%5.72 بنسبة الأنثوية التناسلية عضاءالأ
 بنسبة ملحوظة زيادة رافق (آغم\مغم %001)  PBD ب المستمر العلاج دبع الفئران إناث بخصوبة  التغير نإ
  اتآيميائي فحص عندو .النووي بالحمض تأآسدي إجهاد لوجود آعلامة يعتبر والذي .بالدم  )GDHO-8( بترآيز %8.92
 و القلوي فاتيزبالفوس  ملحوظ انخفاض و  TPG ,TOG في  زيادة لوحظ ,بالفثالات نتحق التي الفئران إناث لدى دمال
 , الكولسترول إجمالي ,البروتين إجمالي ,الثلاثية الدهون ,بالسكر تغير أي يلاحظ لم و .الكرياتينين و اليوريك حمض
  .ئالسي الكولسترول و الجيد الكولسترول
 رالتطو مراحل في خلقية بتشوهات التسبب على الفثالات قدرة حول  أدلة البحث هذا نتائج قدمت ,الختام فيو
 من %22 ب  المعدي الفتق و الامنيسوي الفتق حدوث طريق عن و .المتأخر الفقس وزيادة الفقس معدل تقليل و ,الجنيني
 هذه من جزء .العصبي السلوك بنشاط خلل و تشوهات على يدل مما GNITNIRPMI اختبار بأداء الانخفاض .الحالات
 ارتفاع من يتضح آما الهيكلية العضلات ضمور بزيادة و ,سديالتأآ الإجهاد و النووي الحمض بتلف مرتبطة التشوهات
  .القلوي الفوسفاتيز
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CHAPTER ONE 
 
1. INTRODUCTION 
 
1.1 TERATOGENICITY: 
Teratogenicity is the ability of producing fetal malformation. A wide range of different 
chemicals and environmental factors are suspected or are known to be teratogenic in humans 
and in animals. Classes of teratogens include radiation, maternal infections, chemicals, drugs, 
environmental chemicals, Tobacco, Alcohol, and Caffeine. Exposure to teratogens can result 
in a wide range of structural abnormalities such as cleft lip, cleft palate, dysmelia, 
anencephaly, ventricular septal defect (Shiotak et al, 1982). Exposure to a single agent can 
produce various abnormalities depending on the stage of development it occurs. Several 
factors affect the ability of a teratogen to contact a developing conceptus, such as the nature of 
the agent itself, route and degree of maternal exposure, rate of placental transfer and systemic 
absorption, and composition of the maternal and embryonic/fetal genotypes.(Heudorf et al, 
2007).  
The number of compounds which must be tested for teratogenicity has increased 
dramatically with the continuous development of therapeutic, cosmetic and food additive 
chemicals. It is unrealistic to attempt to perform complete in vivo teratogenicity tests on each 
and every one of these chemicals. Thus quicker, efficient and reliable tests must be developed. 
In the last few years, a number of other systems have been proposed as possible screening 
tests for teratogenicity. The available in vitro systems are – mammalian organ culture, 
vertebrate embryos e.g., chick, fish, and amphibian embryos, invertebrate system like, 
drosophila, cricket and hydra, organ culture e.g. limb bud and cell culture system.( Kotwani et 
al 1994). In addition, pregnancy registries are large, prospective studies that monitor 
exposures women receive during their pregnancies and record the outcome of their births. 
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These studies provide information about possible risks of medications or other exposures in 
human pregnancies. 
SCREENING FOR TERATOGENIC ACTIVITY 
 
 The methods for screening terarogenic activity include (a) studies in rodents and (b) 
surveillance of human epidemiology. Both these methods suffer from disadvantages. The 
former is too expensive for evaluation of a large number of substances. The second method 
i.e., surveillance system detects the teratogenic substances after defect has been produced. 
 
1.1.1 Chick embryo Model 
 
Chick embryo has been used for teratogenicity for many years but the predictive value 
of the chick model has been questioned. Newer techniques have been evolved and by 
standardization of test subjects, chick embryo is coming back as a screening method for 
teratogenicity. Moreover as the list of chemicals which must be tested has grown to an 
intolerable burden the chick embryo has received more favourable review. Several authors 
have described protocols in which the chick is utilized in a predictive test for teratogenicity. 
White leghorn fertilised eggs incubated in commercial apparatus at 30°C are usually used. To 
administer the test agent a hole is bored in the egg, which may be subsequently resealed with 
wax or paraffin. The test agent may be administered to the yolk sac, sub germinal cavity, 
allantois, amnion or air chambers depending upon the physicochemical properties of the 
compound and the individual preference of the investigators. Opinions on the most appropriate 
treatment time vary from 0 hour of incubation to 30 hours, 48 hours or 96 hours. The chick 
may be examined for abnormalities at any time during incubation, at hatching or may be 
allowed to mature to evaluate functional normality. 
Chicks are a suitable model for the evaluation of neurobehavioral teratogenicity 
(Wormser et al 2005) because they provide a rapid and convenient model for screening; 
maternal variables that exist in rodents and other mammals and affect their offspring, such as 
changes in maternal stress, are completely devoid when using avian model (Sastry et al 1991). 
When examining prenatal exposure to different substances, the teratogen is administered 
directly into the media surrounding the embryo, without maternal mediation. Thus the 
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variables related to maternal physiology and behavior are being completely controlled. When 
examining neurobehavioral teratogenicity, the chick is an ideal model since it hatches in an 
advanced developmental stage that allows immediate physical and behavioral evaluation. A 
chick model provides an unlimited, cheap and rapid source for neural progenitors, since it is 
precisely timed and all the embryos are in a known and identical developmental stage 
(Kotwani et al 1995). 
Several avian models for prenatal exposure to teratogens have been developed; it has 
been shown that nicotine, heroin and chlorpyrifos induce behavioral damage demonstrated in 
the imprinting behavioral test, that examines the chick’s tendency to follow the first objects it 
encounter and is related with cholinergic muscarinic signaling in the left intermedial part of 
the hyperstriatum ventral (IMHV) (Izrael et al 2004). 
 
EVENT IN EMBRYONIC DEVELOPMENT 
 
Fertilization before Egg Lying 
 
Division and Growth of Living Cells 
Segregation of Cells into Groups of Special Function (Tissues) 
Between Laying and Incubation 
No Growth; Stage of Inactive Embryonic Life 
During Incubation: 
First Day 
16 hours - First Sign of Resemblance to a Chick Embryo 
18 hours - Appearance of Alimentary Tract 
20 hours - Appearance of Vertebral Column 
21 hours - Beginning of Nervous System 
22 hours - Beginning of Head 
24 hours - Beginning of Eye 
Second Day 
25 hours - Beginning of Heart 
35 hours - Beginning of Ear 
42 hours - Heart Beats 
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Third Day 
60 hours - Beginning of Nose 
62 hours - Beginning of Legs 
64 hours - Beginning of Wings 
 
Fourth Day- Beginning of Tongue 
Fifth Day - Formation of Reproductive Organs and Differentiation of Sex 
Sixth Day - Beginning of Beak 
Eighth Day - Beginning of Feathers 
Tenth day - Beginning of Hardening of Beak 
Thirteenth Day - Appearance of Scales and Claws 
Fourteenth Day - Embryo gets into Position Suitable for Breaking Shell 
Sixteenth Day - Scales, Claws and Beak becoming Firm and Horny 
Seventeenth Day - Beak Turns toward Air Cell 
Nineteenth Day - Yolk Sac Begins to Enter Body Cavity 
Twentieth Day - Yolk Sac Completely Drawn into Body Cavity; Embryo Occupies 
Practically all the Space within the Egg except the Air Cell 
Twenty-First Day - Hatching of Chick 
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Fig (1.1): Successive changes in the position of the chick embryo and its embryonic  
membranes. (From A. L. Romanoff, Cornell Rural School Leaflet, September, 1939) 
 
 
 
1.2 PHTHALATES. 
Phthalates, or phthalate esters, are a class of industrial compounds widely used as 
softeners of plastics like polyvinyl chloride (PVC), solvents in perfumes, toys, food packaging 
and additives to hairsprays, lubricants, and insect repellents. 
 Concerns have been raised about some phthalates because studies on laboratory 
animals have shown that exposure can cause adverse health effects, including effects on 
development of the male reproductive system. Few data are available on the health effects of 
phthalates in humans, but studies show widespread human exposure to phthalates. The 
Environmental Working Group has focused on phthalates since 1998, when bis(2-ethylhexyl) 
phthalate was found in beauty product, found that dibutyl phthalate was present in the bodies 
of every single person tested for industrial pollutants.(Petersen et al.2000) 
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The Table (1.1) Below Represent the most widely used Phthalate 
Compounds and their Metabolites: 
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Fig (1.2): Phthalates Metabolites Chemical Structures 
 
1.2.1 Di (2-Ethylhexyl) Phthalates: 
 
Di (2-ethylhexyl) phthalate, commonly referred to as DEHP, one of the most widely 
used plasticizer; it is predominantly used as a plasticizer in the production of flexible 
polyvinyl chloride (PVC) products. At least 95% of DEHP produced is used as a plasticizer 
for PVC. PVC is made flexible by addition of plasticizers and is used in many common items 
such as wall coverings, tablecloths, floor tiles, furniture upholstery, shower curtains, garden 
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hoses, swimming pool liners, rainwear, baby pants, dolls, toys, shoes, automobile upholstery 
and tops, packaging film and sheet, sheathing for wire and cable, medical tubing, and blood 
storage bags. Numerous nonplasticizer uses of DEHP have been reported; however, it is not 
clear to what extent these uses are, or have ever been, important. Because of concerns 
regarding potential health effects from DEHP exposure, many toy manufacturers have 
discontinued use of DEHP in their products. The use of DEHP in domestically produced baby 
teethers and rattles has been discontinued, and DEHP is also no longer used as a plasticizer in 
plastic food wrap products.(1) 
If you are exposed to DEHP, many factors determine whether you’ll be harmed. These 
factors include the dose (how much), the duration (how long), and how you come in contact 
with it. You must also consider the other chemicals you’re exposed to and your age, sex, diet, 
family traits, lifestyle, and state of health. 
Occupational exposures may be significant, but the highest exposures to DEHP result 
from medical procedures such as blood transfusions (upper bound limit of 8.5 mg/kg/day) or 
hemodialysis (upper bound limit of 0.36 mg/kg/day), during which DEHP may leach from 
plastic equipment into biological fluids (Heudorf et al, 2007) . 
 
1.2.1.1 Medical Tests for DEHP: 
The most specific test that can be used to determine if you have been exposed to 
DEHP is the measurement of MEHP and other breakdown chemicals in your urine or blood. 
This test only provides a measure of recent exposure, since DEHP is rapidly broken down into 
other substances and excreted from your body. You also could be tested for another 
breakdown product (phthalic acid), but this test would not be specific for DEHP. One or 2 
days after exposure, your feces could be tested for the presence of DEHP metabolites. 
 
 
1.2.1.2 DEHP Health Effect: 
One way to see if a chemical will hurt people is to learn how the chemical is absorbed, 
used, and released by the body. For some chemicals, animal testing might be necessary. 
Animal testing might also be used to identify health effects such as cancer or birth defects. 
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Without laboratory animals, scientists would lose a basic method to get information needed to 
make wise decisions to protect public health. Scientists have the responsibility to treat 
research animals with care and compassion. Laws today protect the welfare of research 
animals, and scientists must comply with strict animal care guidelines. 
DEHP, at the levels found in the environment, is not expected to cause adverse health 
effects in humans. A man who voluntarily swallowed 10 g (approximately 0.4 ounces) of 
DEHP had stomach irritation and diarrhea. Most of what we know about the health effects of 
DEHP comes from studies of rats and mice that were given DEHP in their food, or the DEHP 
was placed in their stomach with the aid of a tube through their mouth (David et al, 2000). In 
most of these studies, the amounts of DEHP given to the animals were much higher than the 
amounts found in the environment. Rats and mice appear to be particularly sensitive to some 
of the effects of DEHP. Thus, because certain animal models may not apply to humans, it is 
more difficult to predict some of the health effects of DEHP in humans using information 
from these studies. 
 
In recent years, concern has been raised that many industrial chemicals, DEHP among 
them, are endocrine-active compounds capable of having widespread effects on humans and 
wildlife (Crisp et al. 1998; Daston et al. 1997). Particular attention has been paid to the 
possibility of these compounds mimicking or antagonizing the action of estrogen, and more 
recently, their potential antiandrogenic properties. Estrogen influences the growth, 
differentiation, and functioning of many target tissues, including female and male reproductive 
systems, such as mammary gland, uterus, vagina, ovary, testes, epididymis, and prostate. Thus 
far, there is no evidence that DEHP is an endocrine disruptor in humans at the levels found in 
the environment. 
The wealth of information in animals administered DEHP for periods ranging from a 
few days to lifetime studies indicate that DEHP is a developmental and reproductive toxicant 
by mechanisms not yet completely understood. As discussed below, the mechanisms do not 
appear to involve binding of DEHP to the estrogen or androgen receptors. DEHP administered 
perinatally to females is embryotoxic and teratogenic (reduced fetal body weight, increased 
rates of abortion and fetal resorptions, skeletal malformations and in males, it causes testicular 
toxicity. 
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1.2.2 Phthalates Physical and Chemical Properties: 
Di-esters of ortho-phthalic acid (phthalates) consist of one aromatic ring and two 
usually aliphatic side chains. The phthalates are substances with low water solubility/high fat 
solubility and low volatility. The polar carboxyl group contributes less to the physical 
properties of the phthalates (unless the side chains are very short, as in di-methyl and diethyl 
phthalate).  
 
Fig (1.3): Phthalate Esters         
They are fluid in wide temperature intervals, e.g. between –50ºC and 340ºC for DEHP. Due to 
their low water solubility, the phthalates hydrolyse relatively slowly, but the actual rate varies 
according to solubility and temperature. The properties of phthalates, such as solubility with 
different polymers, volatility, effect on the polymer at different temperatures and so, are 
modified with the side chains. These are most often similar but can also be different. They can 
be straight or branched aliphates but cycloaliphatic and aromatic side groups also occur. The 
physical and chemical properties of the phthalates have made them suitable as plasticisers in 
polymers such as plastic and also rubber. 
 
1.2.3 Metabolism and Kinetics: 
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Fig (1.4) Phthalate Metabolism UDP-GT, Uridine 5’-Diphosphate-Glucuronosyl Transferase. 
Mammalian absorption and metabolism of phthalates (see figure 1.4) are rapid; initial 
de-esterification of one alkyl linkage occurs in the saliva or the gut after oral intake. The 
resulting monoesters have one or more carbons. Monoesters are the main detected metabolites 
of the low molecular weight phthalates, such as DEP and DBP (Silva et al.2007). However, 
phthalate monoesters with five or more carbons in the ester side chain (for example, MEHP, 
MOP, and MNP) are efficiently transformed further to oxidation metabolites. For esters with 
side chains of five or more carbons, the oxidized metabolites are the primary metabolite found 
in urine. Monoesters and oxidized metabolites are excreted free or conjugated as glucuronides-
and to small extent sulfates- and mainly in urine (Silva et al 2003). 
 
1.2.4 Source of Human and Environmental Exposure. 
Wide spread exposure to phthalates has been recently documented among pregnant 
women in Jerusalem (Berman et al 2008). Previous studies in Israel have reported the presence 
of phthalate in soil surface, soil profiles and ground water (Muszkat et al 1993), and in the 
Jordan River. Studies around the world have shown that there is widespread exposure to 
phthalate in the general population. The largest of these studies, the NHANES study in 2.540 
people in the US, found detectable levels for phthalate metabolite (MEP, MBP, MBzP and 
MEHP) in over 75% of the samples (Silva et al 2004). 
Phthalates are easily released into the environment because there is no covalent bond 
between the phthalates and plastics in which they are mixed. As plastics age and break down 
Phthalates 
monoester
Phthalates 
diester 
Free metabolites, 
metabolites glucuronides, 
metabolites  sulfates
monoester 
oxidized 
metabolites 
UDP‐GT, 
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the release of phthalates accelerates. Phthalates in the environment are subject to 
biodegradation, photo degradation, and anaerobic degradation. Phthalate exposure can be 
through direct use or indirectly through leaching and general environmental contamination. 
Diet is believed to be the main source of DEHP and other phthalates in the general population. 
Fatty foods such as milk, butter, and meats are a major source. Low molecular weight 
phthalates such as DEP, DBP, and BBzP may be dermally absorbed. Inhalational exposure is 
also significant with the more volatile phthalates. Phthalates are also found in medications, 
where they are used as inactive ingredients in producing enteric coatings. It's not known how 
many medications are made using phthalates, but some include omeprazole, didanosinee, 
mesalamine, and theophylline. A recent study found that urinary concentrations of monobutyl 
phthalate, the DBP metabolite, of mesalamine users was 50 times higher than the mean of 
nonusers (some formulations of mesalamine do not contain phthalates).[(Hauser et al. 2004) 
another study evaluated whether such associations between use of phthalate-containing 
medications and urinary concentrations of phthalate metabolites may be present by using data 
from NHANES. (Harnandez Diaz et al.2009). 
 
1.2.5 Children’s Susceptibility: 
Children sometimes differ from adults in their susceptibility to hazardous chemicals, 
but whether there is a difference depends on the chemical (Guzelian et al. 1992; NRC 1993). 
Children may be more or less susceptible than adults to health effects and the relationship may 
change with developmental age (Guzelian et al. 1992; NRC 1993). 
There are often differences in pharmacokinetics and metabolism between children and adults. 
For example, absorption may be different in neonates because of the immaturity of their 
gastrointestinal tract and their larger skin surface area in proportion to body weight (Morselli 
et al. 1980; NRC 1993).  The gastrointestinal absorption of lead is the greatest in infants and 
young children (Ziegler et al. 1978). Distribution of xenobiotics may be different. For 
example, infants have a larger proportion of their bodies as extracellular water and their brains 
and livers are proportionately larger (Fomon et al. 1982). The infant also has an immature 
blood-brain barrier and probably an immature blood-testis barrier (Adinolfi 1985). Many 
xenobiotic metabolizing enzymes have distinctive developmental patterns. At various stages 
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of growth and development, levels of particular enzymes may be higher or lower than those of 
adults, and sometimes unique enzymes may exist at particular developmental stages (Komori 
et al. 1990; Leeder and Kearns 1997; NRC 1993; Vieira et al. 1996). Whether differences in 
xenobiotic metabolism make the child more or less susceptible also depends on whether the 
relevant enzymes are involved in activation of the parent compound to its toxic form or in 
detoxification. 
Children are mainly exposed to DEHP orally from mouthing toys and other soft PVC products 
and possibly food, and dermally from handling materials containing DEHP 
 
1.3 PHTHALATES AND HUMAN HEALTH. 
The effects of phthalates on  human health are not yet fully known, but are being 
studied by several government agencies, including the Food and Drug Administration, the 
National Institute of Environmental Health Sciences, and the National Toxicology Program's 
Center for the Evaluation of Risks to Human Reproduction.(1)  
 
Phthalates have been shown to cause a variety of effects in laboratory animals; 
however, their adverse effects on development of the reproductive system of male animals 
have led to particular concern. Those effects include infertility, decreased sperm count, 
cryptorchidism (undescended testes), hypospadias (malformation of the penis) and other 
reproductive tract defects and are referred to as the phthalate syndrome. 
Epidemiology studies consistently linked multiple phthalates to a broad range of health 
effects, starting with birth defects in baby boys and reproductive problems in men, and 
extending to thyroid and immune disruption (Heudorf 2007). 
1.3.1 Effects of Phthalates on Reproduction. 
One of first studies from Harvard School of Public health to link phthalate exposure 
with harm to reproductive health among humans .The study recruited 168 men and found that 
those who had monobutyl phthalate (MBP) or monobenzyl phthalate in their urine tended to 
have lower sperm count. The study shows an inverse relationship between high concentration 
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of these chemicals and low sperm count. There are multiple studies in adult rats in which oral 
exposure to DEHP decreased the weights of the testes, prostate, seminal vesicles, and caused 
atrophy and degeneration of the somniferous tubules with consequent altered sperm measures 
and reduced fertility (Crisp et al, 1998). 
Fertility studies with crossover mating have shown that active phthalates-like DEHP and DBP 
can decrease the fertility of rats and mice through male and female-mediated effects (Lamb et 
al.1987).Phthalates reduce concentrations of testosterone, an important androgen (or male sex 
hormone) that contributes to the development of male sex organs. This androgen deficiency 
causes the phthalate syndrome in laboratory animals if it occurs during time periods that are 
critical for male reproductive development.  
Studies in rodents exposed to doses in excess of 100 mg/kg/day DEHP clearly indicate 
that the testes are a primary target tissue, resulting in decreased testicular weights and tubular 
atrophy (Gray and Butterworth 1980). Within the testis, Sertoli cells appear to be the target of 
DEHP toxicity (Li et al. 2000; Saitoh et al. 1997). Effects on spermatogenesis were also 
indicated by the appearance of damaged spermatogenic cells and abnormal sperm in rats 
exposed to 2,000 mg DEHP/kg/day in the diet for 15 days (Parmar et al. 1987). There are not 
enough data to draw conclusions concerning the role that hormones play in the testicular 
toxicity of DEHP; however, they do appear to have an effect. The co administration of 
testosterone with DEHP appeared to diminish but not abolish the testicular toxicity of DEHP 
in rats (Gray and Butterworth 1980). Luteinizing hormone aggravated the testicular toxicity of 
DEHP in rats (Oishi 1989). 
Few studies have investigated the reproductive toxicity of DEHP in female animals. In 
contrast to males, it is generally thought that the female reproductive system is much less 
sensitive to phthalates. However, recent evidence suggests that phthalates can also induce 
adverse responses in females following pre and post exposure (Grande et al. 2006). Initial 
studies demonstrated that the ovary is a target site for DEHP. Davis et al 1994,  reported that a 
high DEHP dose (2000mg/kg/day) results in prolonged estrous cycles, reduced serum 
estradiol levels and absence of ovulation in adult rats. These data indicate that oral exposure to 
DEHP can affect reproductive processes in female rodents. 
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Studies of long-term exposures in rats and mice have shown that high oral doses of 
DEHP caused health effects mainly in the liver and testes (David et al, 2000). These effects 
were induced by levels of DEHP that are much higher than those received by humans from 
environmental exposures. Toxicity of DEHP in other tissues is less well characterized, 
although effects in the thyroid, ovaries, kidneys, and blood have been reported in a few animal 
studies. The potential for kidney effects is a particular concern for humans because this organ 
is exposed to DEHP during dialysis and because structural and functional kidney changes have 
been observed in some exposed rats (Isenberg et al, 200). 
 
1.3.2 Neurological Effects. 
A new report by Korean scientists, published by Elsevier in the November 15th issue 
of Biological Psychiatry, adds to the potentially alarming findings about phthalates. They 
measured urine phthalate concentrations and evaluated symptoms of attention-
deficit/hyperactivity disorder (ADHD) using teacher-reported symptoms and computerized 
tests that measured attention and impulsivity. They found a significant positive association 
between phthalate exposure and ADHD, meaning that the higher the concentration of 
phthalate metabolites in the urine, the worse the ADHD symptoms and/or test scores. The 
current findings do not prove that phthalate exposure caused ADHD symptoms. However, 
these initial findings provide a rationale for further research on this association. (Kim et al 
2009). 
1.3.3 Developmental Effects. 
DEHP has been demonstrated to cause developmental toxicity including teratogenic 
effects in both rats and mice. Effects observed included decreased fetal/pup body weight, 
increased rates of abortion and fetal resorptions, or malformations. 
In studies of pregnant mice and rats orally exposed to large doses of DEHP, effects on the 
development of the fetus, including birth defects and even fetal death, were observed. 
Researchers observed alterations in the structure of bones and of parts of the brain, and in the 
liver, kidney, and testes of the young animals. These harmful effects suggested that DEHP or 
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some of its breakdown products passed across the placenta and reached the fetus. Therefore, 
humans exposed to sufficiently high levels of DEHP during pregnancy could possibly have 
babies with low birth weights and/or skeletal or nervous system developmental problems, but 
this is not certain (Sastry et al, 1991). Developmental effects of DEHP in rats exposed via 
maternal milk have been studied. Studies in animals also have shown that DEHP or some of 
its breakdown products can pass from mother to babies via the breast milk and alter the 
development of the young animals. This could also happen in humans because DEHP has been 
detected in human milk. (Main et al. 2006) 
A variety of effects were observed in androgen-sensitive tissues of young male rats, 
including reduced (female-like) anogenital distance and permanent nipples, vaginal pouch, 
penile morphological abnormalities, hemorrhagic and undescended testes, testicular and 
epididymal atrophy or agenesis, and small to absent sex accessory glands. (Gray et al. 1999, 
2000; Parks et al. 2000). These morphological effects, as well as reduced fetal and neonatal 
testosterone levels and adult sexual behavioral changes in male rats following gestational and 
lactational exposure, are consistent with an antiandrogenic action of DEHP. The changes in 
the development, structure, and function of the male reproductive tract observed in various 
studies indicate that effects of DEHP on reproduction and development are interrelated 
. 
Musculoskeletal Effects: No studies were located regarding the effect of phthalates on 
human musculoskeletal and no reports of musculo/skeletal effects of phthalates on animals 
were found in any of the studies reviewed. 
 
1.3.4 Cancer. 
The relationship between hepatic peroxisome proliferation, cell proliferation, and 
carcinogenicity has been evaluated in chronic studies of DEHP in rats and mice (David et al. 
1999, 2000). It is well documented that long-term oral exposure to DEHP causes cancer of the 
liver in both rats and mice. There is no evidence that DEHP is genotoxic or a liver tumor 
initiator in rats and mice, although it does appear to have tumor promotion activity. 
 Based on the findings from one of the cancer studies, an NTP bioassay, EPA (Environmental 
Protection Agency) classified DEHP in Group B2 (probable human carcinogen) and derived a 
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cancer risk. Based largely on the same findings, the U.S. Department of Health and Human 
Services suggests that it is reasonable to consider DEHP as a human carcinogen. IARC 
(International Agency for Research on Cancer) recently (2001) updated its cancer 
classification of DEHP from Group 2B (possibly carcinogenic to humans) to Group 3 (not 
classifiable as to its carcinogenicity to humans). In making its overall evaluation of the 
carcinogenicity of DEHP to humans, IARC took into consideration that (1) DEHP produces 
liver tumors in rats and mice by a non-DNA-reactive mechanism involving peroxisome 
proliferation, (2) peroxisome proliferation and hepatocellular proliferation have been 
demonstrated under the conditions of the carcinogenicity studies of DEHP in rats and mice, 
and (3) peroxisome proliferation has not been documented either in human hepatocyte cultures 
exposed to DEHP or in the liver of non-human primates. Based on these three lines of 
evidence, IARC concluded that the mechanism by which DEHP increases the incidence of 
hepatocellular tumors in rats and mice is not relevant to humans. This conclusion is based on 
the assumption that peroxisome proliferation is the mechanism causing liver cancer. 
Even though studies have shown that DEHP can cause liver cancer in rats and mice, the 
mechanism data suggests that these findings may not be relevant to the probability of DEHP 
causing cancer in humans. 
 
1.3.5 Genotoxicity and Teratogenicity: 
DEHP has been tested in a variety of short-term genotoxicity assays with 
predominantly negative or false-positive results. The observation that DEHP causes an early 
transient increase in liver DNA synthesis above a certain dose level is similar to 
Phenobarbital, a known rodent liver tumor promoter (Dalton et al. 2000), and strengthens the 
conclusion that DEHP is an epigenetic tumor promoting agent in rodents. 
 Most of the developmental toxicity evaluations of DEHP are traditionally designed 
studies in which physical development was evaluated just prior to birth in pups of rodents that 
were orally exposed during gestation only. These studies clearly show that gestational 
exposure to DEHP was embryotoxic and teratogenic in rats and mice. A range of effects were 
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observed including intrauterine deaths, skeletal and cardiovascular malformations, neural tube 
closure defects, increased perinatal mortality, and developmental delays. 
 
1.4 MECHANISM OF ACTION. 
1.4.1 Induction of Peroxisome Proliferation 
There is strong evidence that hepatocarcinogenesis of DEHP and other peroxisome 
proliferators is due to their increased production of hydrogen peroxide by peroxisomes and 
enhanced cell proliferation; alteration of mitogenic/apoptotic balance might also contribute. A 
characteristic effect of exposure to DEHP in rodents, particularly rats and mice, is an increase 
in liver weight, associated with both morphological and biochemical changes. Liver 
enlargement is due to both hepatocyte hyperplasia and hypertrophy. Morphological 
examination reveals an increase in both the number and the size of peroxisomes in the liver. 
Peroxisomes are single membrane-limited cytoplasmic organelles found in the cells from 
animals, plants, fungi, and protozoa. Peroxisomes contain catalase, which destroys hydrogen 
peroxide, and a number of fatty-acid oxidizing enzymes, one of which, acyl CoA oxidase, 
generates hydrogen peroxide (Lazarow and deDuve 1976). The main biochemical alterations 
consist of induction of both peroxisomal and microsomal fatty acid-oxidizing enzyme 
activities. The activity of the peroxisomal fatty acid β-oxidation cycle is normally determined 
either by measuring the overall activity (e.g., as cyanide-insensitive palmitoyl CoA oxidation) 
or by determining the first rate-limiting enzyme of the cycle, acyl-CoA oxidase. An important 
observation is that while the β-oxidation cycle enzymes can be greatly induced by peroxisome 
proliferators, other peroxisome enzymes, such as D-amino acid oxidase and catalase, are 
increased to a much lesser extent. This induction imbalance has been postulated to play a 
major role in phthalate-induced liver carcinogenicity. In general, there is good correlation 
between enzyme activity and changes in peroxisome morphometry, allowing palmitoyl-CoA 
oxidation to be used as a specific biochemical marker of peroxisome proliferation. (Lake 
1995) 
 
Induction of peroxisome proliferation following treatment with DEHP is not due to the 
parent compound, but to DEHP metabolites. Studies with MEHP in vitro have demonstrated 
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that the proximate peroxisome proliferators are mono (2-ethyl-5-oxohexyl) phthalate 
(metabolite VI) and mono (2-ethyl-5-hydroxyhexyl) phthalate, (metabolite IX) and that for 2-
ethylhexanol, the proximate proliferators’ is 2-ethylhexanoic acid (Elcombe and Mitchell 
1986). Similar findings were observed by Maloney and Waxman (1999), who showed that 
MEHP (but not DEHP) activated mouse and human PPARα and PPARγ, while 2-
ethylhexanoic acid activated mouse and human PPARα only, and at much higher 
concentrations. Based on its potency to induce enzyme activities, such as the peroxisomal fatty 
acid β-oxidation cycle and carnitineacetyltransferase, DEHP might be considered a relatively 
weak proliferators’. 
The role of PPAR in peroxisome proliferators-induced toxicity has been examined in 
several studies. In a study by Ward et al. (1998), treatment of PPARα wild-type mice with 
DEHP for up to 24 weeks resulted in typical up regulation of mRNA for peroxisomal and 
CYP4A enzymes in the liver and kidney, while treated null mice were no different from 
control wild-type or null mice. Whereas treated wild-mice had liver, kidney, and testicular 
toxicity, treated PPARα-deficient mice did not exhibit liver toxicity, but showed delayed 
moderate kidney and testicular toxicity. This suggested that while DEHP-induced liver 
toxicity is mediated solely by PPARα activation, both renal and testicular toxicities have both 
a receptor- and nonreceptor-mediated response. 
A study using human hepatoma cells expressing PPARα, β/δ, or γ showed that the 
DEHP MEHP, activated all three isoforms of PPAR in a dose-related fashion, but DEHP did 
not (Lapinskas andCorton 1997). In addition, the metabolite 2-ethylhexanoic acid was 
isoform-specific since it activated PPARα but not β/δ or γ. These data are consistent with 
observations in vivo and in vitro indicating that the toxicity of DEHP is due mainly to MEHP. 
The exact mechanism(s) by which peroxisomal proliferating agents such as DEHP induce 
hepatic cancer in rodents are not precisely known, but might be related to the modulation of 
peroxisomal β oxidation, the PPAR α receptor, gap junctional intercellular communication, 
and replicative DNA synthesis (Isenberg et al. 2000, 2001). Two major mechanisms have been 
proposed to account for peroxisome proliferators-induced hepatocarcinogenicity in rodents: 
induction of sustained oxidative stress and enhanced cell proliferation and promotion. 
Suppression of hepatocellular apoptosis has also been suggested to play a role. 
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In Summary, there is strong evidence that hepatocarcinogenesis of DEHP and other 
peroxisome proliferators is due to their increased production of hydrogen peroxide by 
peroxisomes and enhanced cell proliferation; alteration of mitogenic/apoptotic balance might 
also contribute. These events are triggered by the activation of gene expression via a nuclear 
receptor, PPARα. It should be noted that if liver cancer in humans can be promoted by DEHP 
via a mechanism not involving peroxisome proliferation (i.e., inhibition of gap junctional 
intercellular communication), the fact that this was not measured in human liver and that 
promotion must occur on initiated liver cells for long periods of time at a concentration that 
exceeds a potential threshold level (a characteristic of chemical tumor promoters) might still 
implicate DEHP as a potential human liver tumor promoter. However, because the model 
chemical, Phenobarbital, is also a rodent tumor promoter and has not been shown to be a 
human liver tumor promoter, it is reasonable to conclude that normal exposures to DEHP will 
not be a significant risk factor for human liver cancers. 
 
1.4.2 Oxidative Stress: 
Several investigators have hypothesized that liver tumor formation arises from an 
imbalance between hydrogen peroxide generation and degradation within the peroxisome 
(Rao and Reddy 1987; Reddy and Lalwani 1983; Reddy and Rao 1989). This imbalance is the 
result of a much greater induction by peroxisome proliferators of hydrogen peroxide-
generating enzymes than induction of catalase. This might be compounded by a reduction in 
enzyme activities that detoxify active forms of oxygen and organic hydroperoxides. Hydrogen 
peroxide that escapes the peroxisome might damage intracellular membranes and/or DNA 
(Reddy and Rao 1989). Lipid peroxidation and lipofuscin deposition have been observed in 
hepatocytes from rats treated with DEHP and other peroxisome proliferators (Cattley et al. 
1987; Conway et al. 1989). Tagaki and coworkers have examined the possibility of DNA 
damage by DEHP by measuring the induction of 8-hydroxydeoxyguanosine (8-OH-dG), a 
marker of DNA oxidation, in the liver and kidney from male rats administered DEHP for 
various periods of time (Sai-Kato et al 1995). Increased levels of 8-OH-dG were seen in the 
liver after 1 or 2 weeks or 12 months of treatment, but no increases were seen in the kidney. In 
general, the increases were small (2-fold) and in some cases, were not sustained with 
prolonged DEHP treatment (Cattley and Glover 1993). Moreover, the increased levels of 8-
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OH-dG do not correlate with carcinogenic potency, as similar levels of induction have been 
associated with divergent carcinogenic activities (Marsman et al. 1988, 1992). Furthermore, 
DEHP and other peroxisome proliferators have consistently lacked initiation activity unlike 
other DNA-damaging agents. The overall evidence suggests that increased production of 
hydrogen peroxide and DNA oxidation are not solely responsible for peroxisome proliferators-
induced liver tumor formation. 
 
1.4.3 Effects on Reproductive System. 
The role of zinc in DEHP-induced testicular atrophy has been examined in several 
studies since a reduction in testicular zinc is a primary event following administration of 
DEHP. A decrease in testicular zinc, but not in serum or liver zinc, was reported in rats given 
DEHP (Oishi 1985). After a 45-day recovery period, when there was morphological evidence 
of seminiferous tubule regeneration, testicular zinc was still lower than in controls (Oishi 
1985). Simultaneous oral administration of DEHP and oral or intraperitoneal administration of 
zinc did not prevent testicular atrophy in rats, and zinc supplementation did not increase the 
concentration of zinc in the testis despite increases in liver and serum (Oishi and Hiraga 
1983). This suggested that DEHP-induced testicular effects do not result from interference 
with gastrointestinal absorption of zinc, but that atrophy might be related to endogenous 
testicular zinc, thus, cannot be prevented by zinc supplementation (Oishi 1985). 
The effects of DEHP on hormones that influence testicular maturation and function 
have also been explored. As was the case with zinc. DEHP administered to mice significantly 
reduced the concentration of testosterone in the testis, but no testicular atrophy was observed 
(Oishi1980). Increases in testicular concentration of testosterone along with decreases in 
testicular content of testosterone seen after DEHP treatment suggested that testosterone-
producing Leydig cells are normal, but that the total number of cells is less than in controls or 
that the cells are less active in testosterone production (Oishi et al, 1985). 
In a later study, Oishi (1989) reported that co-administration of DEHP and testosterone 
apparently aggravated the testicular damage caused by DEHP, an effect that seemed to be due 
to testosterone prolonging the biological life and the mean residence time of MEHP in the 
testis. A mechanism for such an effect was not discussed. In a similar study, luteinizing 
  ‐ 22 ‐
hormone-releasing hormone significantly enhanced the testicular toxicity of DEHP when 
given together with DEHP (Oishi et al. 1989). 
Results from both in vivo and in vitro studies have indicated that the Sertoli cell is the 
main target for DEHP-induced testicular toxicity and that MEHP is the ultimately active 
testicular toxicant (Chapin et al. 1988; Gray and Beamand 1984). However, effects on Leydig 
cells have also been reported (Jones et al. 1993). The Sertoli cell is a somatic cell type whose 
integrity and functionality is required for the growth and maintenance of the germ cells as they 
divide and differentiate from spermatogonia to spermatocytes and ultimately to spermatids. 
The latter are released by the Sertoli cell into the lumen as sperms. Gray and Butterworth 
(1980) had suggested that Sertoli cell and not the germ cell was the direct target of DEHP 
toxicity since the germinal cells affected were those inside the Sertoli cell barrier. Alterations 
in Sertoli cell cytoskeleton after exposure to phthalates also have been reported (chapin et al, 
1988). 
 
1.5 ANIMAL TO HUMAN EXTRAPOLATIONS: 
 
There is ample evidence suggesting that there are species differences in both the 
pharmacokinetics and toxicity of DEHP; strain differences have also been described. In some 
cases, the differences in toxicity can be explained by differences in pharmacokinetics. The 
issue of greatest importance to be considered is whether DEHP can induce liver cancer and 
reproductive toxicity in humans, as seen in rodents. As previously mentioned the 
hepatocarcinogenic response to DEHP in rats and mice is associated with peroxisome 
proliferation and increased hepatocyte replication. Studies in animals have shown that after 
exposure to peroxisome proliferators, rats and mice exhibit the greatest response, hamsters 
exhibit an intermediate response, whereas primates, guinea pigs, and dogs are either 
unresponsive or refractory (Cattley et al. 1998). 
Elcombe and Mitchell (1986) isolated MEHP metabolites from rat urine and tested them in 
cultures from rat, guinea pig, marmoset, and human liver. Metabolite VI, biochemically and 
morphologically identified as the proximate proliferators in the rat, had little or no effect in 
marmoset, guinea pig, or human hepatocytes. These findings suggested the existence of 
intrinsic species differences of liver cells to peroxisome proliferators. 
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If peroxisome proliferation and liver carcinogenicity is mediated by PPARα, the species 
differences could reflect either variation in PPARα itself or in the gene networks regulated by 
PPARα (Green 1995). However, MEHP activated both human and mouse PPARα and both 
preparations were equally sensitive. This suggested that differential sensitivity of human 
PPARα cannot alone account for the lack of peroxisome proliferation response seen in 
humans, but other factors, such as the much lower level, as found by Palmer et al. (1998), are 
also likely to be important. Another important factor might be species differences in 
responsiveness of genes to PPARα-mediated transcription. 
As for testicular toxicity, which does not seem to be related to peroxisomal 
proliferation to the extent that liver cancer is, differential sensitivity among animal species has 
been found. Studies in vivo have shown that rats and guinea pigs are highly sensitive while 
mice are fairly sensitive, and hamsters and monkeys are highly resistant (Gray et al. 1982; 
Kurata et al. 1998). 
A lack of information precludes ranking humans relative to other species. Differences 
in pharmacokinetics might play a role in the differential sensitivity between species, but 
differences in tissue sensitivity might play a role as well mixed cultures of Sertoli cells and 
germ cells from rat testes were more sensitive to MEHP toxicity than cultures from hamster 
testes (Gray and Beamand 1984). Also, cultures from older rats were less sensitive than 
cultures from young animals, suggesting that intrinsic cell factors might account for different 
susceptibility. Studies with the knockout mice for PPARα have suggested that other receptor 
subtypes (PPARδ or γ) might play a role in the delayed testicular toxicity observed in these 
mice or that the high dose of DEHP might modify the pharmacokinetics of DEHP in the (-/-) 
mice (Ward et al. 1998). 
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Fig (1.5):  Existing information about the Effect of DEHP on Human Health 
1.6  LEGAL STATUS: 
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In Europe, any substance known or suspected to be carcinogenic, mutagenic or to 
cause reproductive effects in laboratory animals at any dose cannot be used in cosmetics this 
Includes phthalates such as dibutyl phthalate. The restriction states that the amount of 
phthalates may not be greater than 0.1% mass percent of the plasticized part of the toy. Some 
phthalates are allowed at any concentration in other products and other phthalates are not 
restricted. (2) 
 
 
1.7 AIMS OF THIS STUDY: 
-   This study is designed to establish a chick model for the evaluation of the developmental 
effects of phthalates using pre- and posthatch developmental markers. 
-   To see whether pre-hatch exposure to phthalates can effect behavioral development and 
whether the behavioral defects may be related to DNA damage. 
-   To study the biochemical changes in blood serum of animals pre-treated with phthalates 
compared to untreated controls 
 
-  To provide public health officials, physicians, toxicologists, and other interested individuals 
and groups with an overall perspective on the toxicology of DEHP and DBP. 
 
-  To understand the reasons for differences in susceptibility to phthalates based on species 
differences. 
 
 
CHAPTER TWO 
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MATERIALS AND METHODS 
 
2.1  CHEMICAL AND REAGENTS: 
           Dibutylphthalate (DBP) and Bis(2-ethylhexyl)phthalates (DEHP)  were purchased from Sigma 
Aldrich. DNA Damage ELISA Kit from Assay Designs, Inc. 5777 Hines Drive, Ann Arbor, 
MI48108USA. Kits for biochemical assays from SEPPIM S.A.S. –Zone Industrielle - 61500 SEES 
France. All chemicals and drugs were of analytical grade and were purchased from Sigma Chemicals 
Co P.O.Box. 14508, St. LouisMO.63178USA. Dextrostix strips were purchased from Ames, (Miles, 
Paris) 
2.2   CHICKS MODEL FOR TERATOGENIC ACTIVITY:   
Chick Model Teratogenic Activity: As developed by Yani et al (2008). 
2.2.1 Teratogen Treatment: 
Fertile chicken eggs (Gallus gallusdomesticus) of the Lohmann line of the leghorn 
breed were obtained from a local breeder and placed in an incubator. To administer the DEHP, 
a hole was drilled in the chorioallantois end (pointed end) of the shell and was sealed with 
medical silicon (type A, Dow Corning). (DEHP), dissolved in corn oil was then administered 
on incubation day (ID) 0 with at doses of 5, 20, 50, and 100 mg/kg egg. Control eggs received 
equivalent volumes (60µl/kg of egg) of corn oil vehicle solution. Eggs were placed in a 
commercial incubator at 37.5 °C with 50-60% humidity. Embryonic survivals were monitored 
via candling and hatch rate and physical attributes at hatching were noted. The chicks were 
trained to follow an imprinting object and were tested for imprinting performance. 
2.2.2 BEHAVIORAL TESTS: 
2.2.2.1 Testing of Imprinting: 
As modified from earlier descriptions by McCabe et al 1981, the chicks were 
transferred to the imprinting apparatus contained three 20 cm diameter running wheels with 
the sides covered with black, permitting the chicks to see only forward or backward. The 
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imprinting objects were an illuminated red box or a bule cylinder (both 15x10x18 cm high), 
located 50 cm from the front open side of the running wheel, lit from within by a 40W bulb 
with holes covered with red or blue filters. Imprinting training and testing will be both 
assessed with this apparatus. 
The chicks were hatched in total darkness and handling was done in the dark, aided by 
a dim green light, which has a minimal effect on imprinting (Kovach et al 1971). Each chick 
was tagged and then transferred to an individual dark, enclosed wooden chamber warmed to 
30 °C where they were physically and visually isolated from each other. Fourteen to twenty-
four hours post-hatch, the chicks underwent 45 min of “priming” 30 min exposure to a light 
followed by 15 min of darkness. Immediately after, they were placed individually on the 
running wheel for training. The chicks were divided into group trained for 60 min with either 
blue or red imprinting objects. The numbers of wheel rotations made by the chick towards or 
away from the imprinting object were recorded by a self-made computerized system. After 
training, the chicks were returned to the enclosed chambers for 60 min, after which testing 
took place. Recorded maternal calls were played continually throughout training but not 
during testing.     
There were four testing sessions in counterbalanced randomized order, each lasting 5 
min; in two of the tests, the chick was allowed to run toward the imprinting rotating object and 
in the other two, toward the control rotating object. The red-light box was used as the 
imprinting object and the blue-light box served as the control object for chicks trained to 
follow a red object and vice versa for the chicks trained to follow the blue-light box. The 
number of wheel rotations completed by the chick toward the imprinting or the novel (control) 
object, and the running away (backward) from the objects was recorded by the apparatus.  
The imprinting is expressed as preference scores where: Preference score = Running toward 
the training light / (Running toward the training light + Running toward a novel light). The 
preference score is a measure of the strength of learning; assessing the selective preference 
that arises from the experience of the training object (Sluckin et al 1972). The expected range 
of the preference score is 0.0-1.0, where 0.5 indicates no imprinting. 
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2.2.2.2  Locomotor Activity: 
Locomotors activity influences the number of wheel rotations, it’s the number of 
rotations of the wheel made by the chicks during training (Forward and backward).                       
The locomotor activity during imprinting testing (both training and novel lights) is expressed 
as the total number of rotations of wheel (forward and backward) made by the chicks. 
 
 
 
 
 
 
 
 
 
2.3   RATS MODEL OF FERTILITY: 
 
2.3.1   Experimental Design for Fertility Studies: 
 Healthy White Albino female rats weighing 120-200 g each were used in these 
experiments. Animals were divided into three groups, 6 animals in different cages. Group B 
was treated with DBP 100 mg / kg, group C was treated with the same dosage of DEHP, and 
group A was treated with vehicle solution of Corn Oil.  All the experimental animals in groups 
A, B, C, were maintained under normal conditions of humidity, circadian cycle and 
temperature and with free access to food and water unless required otherwise. A standard rat 
pellet diet was used for all the experiments. 
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The female rats were injected intraperitoneally (IP) twice a week with DBP or DEHP 
100 mg/kg body mass and control group was injected (IP) with the same volume of Corn Oil. 
Each week rats were fasted for 15 hours for the measurement of body weight and blood 
glucose. After one week females were cohabited for one month with two male rats in each 
cage, and to avoid aspects of male fertility the male rats were distributed equally between the 
cages. Thus the females in group A, B and C were exposed equally to the same male rats. All 
the male rats were not treated with the drugs. After one month of exposure the male rats were 
removed and we continued to measure the body weight, blood glucose, and to follow up 
carefully the cases of pregnancy, until delivery. During this period we recorded the number of 
pregnant females and the number of litters in each delivery for the measurement of mortality 
rate, fertility rate and fecundity rate. In addition we observed carefully the appearance of any 
behavioral changes including motor disorders on female rats or the new born litters. 
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PROTOCOL OF EXPERIMENTS 
 
1ST DAY: Measurements of total body weight and glucose in fasted female rats 
divided into three groups 
 Group A:  Control Treated with Corn oil 0.2 ml 
 Group B  Treated with DBP (100 mg/kg) 
 Group C:  Treated with DEHP (100 mg/kg) 
 Injections of 0.2 ml of each drug were made i.p twice a week for 67 
days 
7th Day: Female rats were Cohabited with two male rats for mating. 
37th Day: Male rats were removed. 
67th Day: Female fasted rats were anaesthetized with ether for: 
a) Removal of  blood samples from the femoral artery for: 
- Biochemical Measurements 
- DNA  Damage Measurements 
b) Removal of Internal organs for the measurement of Relative 
weight of: heart, kidneys, spleen, liver, brain and Sex organs. 
**   Pregnant female rats were separated and on delivery the number of new born 
litters was counted. 
2.3.2   Total Body Weight and Relative Weight of internal Organs 
  ‐ 31 ‐
At the end of experiment rats were anaesthetized with ether and the following organs 
were removed for the measurement of absolute and relative weight. Heart, kidneys, spleen, 
liver, brain. sex organs including the ovaries, oviducts, uterus and vagina.   
Blood samples were collected from the femoral artery for separation of blood serum and 
measurement of blood biochemistry and DNA damage. 
 
2.4. BIOCHEMICAL MEASUREMENTS: 
During examination rats were anaesthetized with ether and at the stage of light 
anesthesia characterized by loss of pain sensation and somatic motor activity with positive 
corneal reflex, 1 ml blood was drawn from the femoral artery into a test tube. Blood sample 
was centrifuged at 2000 g for 10 min; serum was isolated and stored at – 80 °C for Biochemical 
analysis and DNA damage test. 
2.4.1   Measurements of Blood Glucose: 
Blood samples for glucose analysis were taken from the tail tip, and plasma glucose was 
measured using Glucometer instrument and Dextrostix strips (Washka& Rice 1961). 
 
2.4.2   Measurements of Basic Biochemical Compounds: 
 Cholesterol Total, Cholesterol HDL and LDL, Triglycerides, Total protein, Urea, Uric 
acid Creatinine were all determined by the colorimetric assay of ( Eli-Tech diagnostics) 
Following the Kits instructions. 
Enzymatic colorimetric determination of total cholesterol was measured according to 
the method described by Tietz (1995), and Vassault et al (1999). Cholesterol HDL Direct was 
measured as described by Rifai et al 2001. Cholesterol LDL Direct was measured as described 
by Rifai et al 2001 and Naito 2003. With total protein we used the Biuret reaction as described 
by Christensen 1983 and Scherwin 2003 and for the enzymatic colorimetric measurement of 
triglycerides we used the method as described by Naito 2003 and Fossati&Prencipe 1982. Urea 
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was measured as described in details by Newman and Price 2001, Uric acid acid determination 
as described by Tietz  1995. While Creatinine according to Allston 1993. 
 Following the Kits instructions, total protein is expressed in g/dl while all the other 
compounds as glucose, urea, uric acid, creatinine, triglycerides, cholesterol total, cholesterol-
HDL and cholesterol-LDL are expressed as mg/dl. 
 
2.4.3   Enzymatic Measurements: 
In these experiments the activity of the following enzymes were measured. Kinetic 
determination of Alkaline phosphatase (AlP) was measured as reported by the Scandinavian 
Society of Clinical Chemistry  (1972) and the German Society for clinical chemistry (1972). 
Alanine aminotransferase (ALT/ GPT) activity was measured as reported by (Schiele 1982) and 
Aspartate aminotransferase (AST / GOT) as reported by expert panel of the IFCC (1976). In all 
cases enzyme activity was expressed as U/L,  
 
2.5.    MEASUREMENT OF DNA DAMAGE: 
Assay Designs’ DNA Damage ELISA (enzyme-linked immunosorbent assay) is a fast 
and sensitive competitive immunoassay for the detection and quantitation of 8-hydroxy-2’-
deoxyguanosine (8-OHdG) in serum as well as urine samples. 8-OHdG has become a 
biomarker of oxidative DNA damage and oxidative stress, the method uses an 8-OHdG 
monoclonal antibody to bind in a competitive manner. Details of the procedure are described in 
details in catalog number: EKS-350, and as published previously (Chiou et al 2003; Lezza et al 
1999 ; Alam et al 1997). DNA Damage ELISA Kit was used for detection and quantitation of 
8-hydroxy-2’-deoxyguanosine in serum samples of controls and treated animals. 
 
 
 
ASSAY PROCEDURE SUMMARY: 
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1. 8-OHdG Immunoassay Plate, 20X Wash Buffer, Sample Diluent, Antibody Diluent, HRP 
Conjugate Diluent, TMB Substrate and Stop Solution 2 were brought to room 
temperature. 
 
2. 8-OHdG Standard and samples were prepared in Sample Diluent. 
 
3. 50µL prepared standards and samples in duplicate were added to wells of 8-OHdG 
Immunoassay Plate. 
 
4. 50µL diluted Anti-8-OHdG was added to each well, except the blank. Immunoassay plate 
was then covered. 
 
5. Plate was incubated at room temperature for 1 hour. 
 
6. Wells 6X were washed using 300µL/well of 1X Wash Buffer. 
 
7.  100µL diluted Anti-Mouse IgG: HRP Conjugate was added to each well, except the blank. 
Immunoassay plate was then covered. 
 
8.    Plate was incubated at room temperature for 1 hour. 
 
9.    Wells were washed 6X using 300µL/well of 1X Wash Buffer. 
 
10.  100µL TMB Substrate was added to each well. 
 
11.  Incubation took place at room temperature for 15 minutes (in the dark). 
 
12.  100µL Stop Solution 2 was added to each well. 
 
13.  Absorbance was measured at 450nm. 
 
14. The 8-OHdG standard curve was plot and 8-OHdG sample concentrations were calculated.  
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2.6.     STATISTICAL ANALYSIS: 
All values are presented as Mean ± SEM for the number of experiments indicated in 
brackets and the data were analyzed using Students t-test. 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER THREE 
 
RESULTS 
 
3.1 TERATOGENIC ACTIVITY OF PHTHALATES ON CHICKS DEVELOPMENT: 
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3.1.1 EFFECT OF PHTHALATES ON HATCHING AND DEFECT PRODUCTION 
Teratogenic activity of DEHP and DBP was tested on chicks embryonic 
development. Eggs were injected before incubation with 60 µl DBP (100 mg/kg egg) or 
DEHP 5 to 100 mg/kg.  Control eggs were treated with the same volume of corn oil. 
Table 3.1 and Fig 3.1 show that that eggs which were injected with the vehicle 
solution,  produced 80 % hatching, and all the new born chicks were normal without any 
defects. Eggs which were exposed to DEHP 5 mg/kg, percentage hatching was reduced to 
64 % without having any defects. Higher dose of 20 mg/kg has decreased percentage 
hatching to 62 %,  and  produced 8 % defects. The chicks were born with a hole in 
abdominal muscles, allowing the intestinal track to protrude externally without a sac, a 
pathological case called (Gastroschisis) Fig 3.1.B. Higher doses of DEHP (50 mg/kg), and 
(100mg/kg) produced similar percentage of hatching but increased percentage defects by 
11 % and 22 % respectively. The types of defects were mixed, Gastroschisis and 
Omphalocelewhere the internal organs are protruded externally in a translucent sac, (Fig 
3.1- C + D). 
Eggs treated with DBP 100 mg/kg reduced percentage hatching from 80% to 57 % 
and increased percentage of defective chicks from 0 % in control eggs to 14 %. All the 
defective chicks were Gastroschisis and animals were not able to move or stand on their 
legs as shown in (Fig. 3.1 – E). 
Late hatching in control eggs was 15.6 %, in DEHP treated eggs 29.4 %, and DBP 37.5 % 
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TABLE – 3.1 
TERATOGENIC ACTIVITY OF BIS(2-ETHYLHEXYL) PHTHALATES 
(DEHP) &DIBUTYLPHTHALATES (DBP) ON CHICKS DEVELOPMENT 
   CONTROL   DEHP      DBP 
                5 mg/kg     20mg/kg      50 mg/kg   100 mg           100 mg/kg
      
NUMBER OF EGGS:       40    11          13                    19            9            14 
(CANDLING  EGGS)      
HATCHING:         32      7          8                   13            6              8  
% HATCHING:       80 %   64 %       62 %               68 %        67 %          57 % 
NORMAL HATCHING:        22      6          7     6            5             5 
LATE  HATCHING:          5        1          1    7             1              3 
  
DEFECTS:           0       0          1     2             2               2 
% DEFECTS:         0 %                  0 %        8 %            11 %          22 %                     14 % 
OBSERVATIONS: Normal         Normal    *(1)            * (1)            ** (2)               * (1) 
                 ** (1) 
                                                *** (1) 
*Gastroschisis:   Hole in or weakening in abdominal muscles, allowing internal organs to  
protrude externally. Without a Sac. 
**Omphalocele: Hole in or weakening in abdominal muscles, allowing internal organs to 
protrude externally in a Translucent Sac.   
***Motor Disorders: Not able to move or stand on his legs         
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FIG 3.1  THE EFFECT OF PHTHALATES ON DEVELOPING CHICKS 
 
    A)Normal Chicks   (Control)                                    B) 20 mg/kg DEHP 
 
   
          (Normal)          (Gastoschisis) 
 
                                                C)  50 mg/kg DEHP 
 
   
(Omphalocele)     (Gastroschisis) 
                                                D)    100 mg/kg DEHP 
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       (Omphalocele)             (Omphalocele) 
 
 
       E)100 mg/kg  DBP 
 
    
              (Gastroschisis)       (Motor Disorder) 
 
 
3.1.2 BEHAVIORAL TEST: 
 
3.1.2.1 IMPRINTING TEST:   
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Preference ratio in control chicks and chicks with prehatch exposure to DEHP. Data 
represent mean ± SEM obtained from 6 control and 9 DEHP-exposed chicks. * p< 0.05 for 
the difference between the groups. 
Imprinting preference score in the control group was 0.649 (Table 3.2) and (Fig.3.2), well 
above the “no preference” score of 0.5 (p<0.001). Prehatch exposure to DEHP decreased 
the imprinting score to 0.509 (p<0.05). The percentage decrease in neurobehavioral test is 
21.6 % (p<0.05) 
 
TABLE – 3.2 
IMPRINTING TEST ON CHICKS TREATED WITH BIS(2-ETHYLHEXYL) PHTHALATES 
(DEHP) 
 
CONTROL:    0.649   ±   0.041 (6) 
Eggs injected with 60µl Corn Oil 
TREATED:    0.509   ±   0.023 (9) 
Eggs Injected with DEHP 
(50 – 100 mg/ kg)  
%  CHANGE:   ↓21.6 % 
       P≤0.05 
DEHP was injected ip in doses of 50 and 100 mg/kg and in a volume of 60µl into 
fertilized eggs before incubation. Control eggs were injected with the same volume of corn oil. 
Candling eggs were kept in complete darkness before hatching for imprinting test. 
 
Fig 3.2  Preference Score of Imprinting Test  
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* p<0.05 
 
3.1.2.2  Locomotor Activity: 
 
We assessed locomotor activity (The number of rotations of the wheel made by the 
chick during training). Since locomotion can be itself influence imprinting. 
The locomotor activity during imprinting testing (both training and control light) was 
expressed as the total number of rotations of the wheel made by the chicks (Table 3.3). 
 We evaluated general activity to exclude potential confounding effects on activity 
in the imprinting evaluations. Whereas DEHP has an effect of 28 % increase on activity 
during training although it was not significant. Activity during testing was not changed 
significantly. 
 
Table 3.3 
 
The Effect of Prehatch Exposure to Phthalates on the Activity Level 
(Wheel Rotation during Training (left) and during Testing (right) 
 
TREATMENT                    ACTIVITY DURING TRAINING            ACTIVITY DURING TESTS 
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CONTROL                                158.6  ±  45.1 (7)                                       50.0  ±  8.6 (8) 
 
DEHP                                      203.0  ±  55.4 (10)                                     42.2  ±  11.2 (11) 
 
% CHANGE                             ↑  28 %                                                         ↓  15.6 % 
 
P                                                   NS                                                                  NS 
 
 
There were no statistical significant differences between control and DEHP exposed group 
between activity during imprinting training and imprinting testing. 
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3.1.3   BIOCHEMICAL MEASUREMENTS IN CHICKS SERUM: 
 
Pre-hatch exposure of eggs to Phthalates has produced the following biochemical 
changes in blood serum of non-fasted chicks (Table 3.4). 
Alkaline phosphatase activity was increased significantly by 296 % from 90.00 ± 25.50 
(4) to 357.00 ± 73.00 (8) (U/L) (P ≤ 0.05), and GPT activity was decreased by 76 % from 
32.00 ± 8.20 (6) to 7.82 ± 2.06 (11) (U/L) (P ≤0.05) , while urea was reduced by 41 % from 
64.15 ± 4.10 (4) to 37.72 ± 2.83 (12) (mg/dl) (P ≤ 0.05), and creatinine by 69 % from 1.67 ±  
0.38 to 0.51 ± 0.07 (10) (mg/dl) (P ≤0.05). 
No significant changes were observed in cholesterol total, cholesterol-LDL, 
cholesterol-HDL, total protein, triglycerides, and glucose or on the activity of GOT enzyme.
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TABLE – 3.4 
BIOCHEMICAL CHANGES IN CHICKS TREATED WITH BIS(2-ETHYLHEXYL)  
PHTHALATES (DEHP)  
     CONTROL   PHTHALATES 
GLUCOSE: (mg/dl)   232.60  ± 11.4 (6)  207.04  ± 10.19 (10) 
ALKALINE PHOSPHATASE: (U/L) 90.00± 25.50 (4)  357.00  ± 73.00 (8)  
  
GPT: (U/L)    32.00  ± 8.20 (6)  7.82  ± 2.06 (11)*  
GOT: (U/L)    148.80  ± 11.7 (5)  164.33  ± 15.44 (12)  
UREA:  (mg/dl)  64.15 ± 4.10 (4)  37.72  ± 2.83 (12) **  
CREATININE(mg/dl)   1.67 ± 0.38 (4)  0.51 ± 0.07 (10)*  
URIC ACID: (mg/dl)   7.37 ± 1.90 (6)  5.22  ± 0.58 (12)  
TOTAL PROTEIN: (g/dl)   3.13± 0.56 (6)                2.28  ± 0.11 (11)  
CHOLESTEROL – TOTAL:(mg/dl)    396.00  ± 36.06 (6)  378.91  ± 16.89 (11)  
   
CHOLESTEROL- HDL  (mg/dl)  155.60  ± 11.8 (5)  149.55  ± 7.81  (12)  
 
CHOLESTEROL – LDL  (mg/dl)  261.00  ± 35.00 (6)  207.04  ± 10.19 (10)  
 
TRIGLYCERIDES: (mg/dl)   103.50 ± 16.00 (6)  68.15 ± 3.50 (12)  
Values shown are Mean ± SEM for the number of experiments indicated in brackets. At the end 
of each experiment, blood was collected from the common carroted artery of chicks, centrifuged and   
blood serum  was separated for the measurement of  biochemical compounds. Analysis was performed 
using Bio-analyzer for measuring all the chemical compounds.* P ≤ 0.05    ** P ≤ 0.02 
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3.1.4   CHICKS DNA DAMAGE: 
 DNA damage was estimated by measuring the concentration of 8-OHdG in blood 
serum of new born chicks. Fig. 3.3 shows that pre exposure to DEHP has increased 8-OHdG 
significantly by 39.7 % (P ≤ 0.05), while the 25 % increase induced by DBP was not 
significant. 
 
FIG. 3.3   EFFECT OF DEHP & DBP ON CHICKS DNA DAMAGE 
 
 
Values are Mean ± SEM and measured in ng 8-OHdG in  ml blood  for 6 control chicks,  
3 chicks treated with DBP and 6 chicks treated with DEHP. * P ≤ 0.05, NS = not significant. 
3.2 EFFECT OF PHTHALATES ON RATS FEMALE FERTILITY: 
3.2.1 EFFECT OF PHTHALATES ON FERTILITY RATE, FECUNDITY & MORTALITY RATE 
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 In control samples, female rats were injected (I P) with 200 µl corn oil twice a week for 
3 months and cohabited with adult male rats for a period of one month. Female rats produced 
pregnancy in 87% of the cases (13 / 15). Each pregnant female rat delivered between 6 – 12 
litters (an average of 8.2 litters per delivery), and average weight of each litter is 7 to 8 grams. 
All the new born litters developed normally. Mortality rate was 2.8 %, since 3 litters died from 
a total number of 106 litters. 
 Female rats which were injected (I P) with DBP 100 mg / kg twice a week and were 
cohabited for one month with male rats. DBP has reduced fertility rate from 87 % in control 
group to 67 % (6 female rats got pregnant from a total number of 9 rats (Table 3.5). Fecundity 
rate was reduced to 7.3 litters per delivery and mortality rate was increased to 52.3 %. Litters 
weight round 6 gram each. Observation studies have shown 2 cases with motor disorders, one 
rotating (10 rotations per min.) and one rearing (5 times per min.). 
 Other group of female rats was injected (IP) with DEHP 100 mg / kg for the same 
periods and cohabited with the same male rats for a period of one month. Treatment with 
DEHP decreased fertility rate to 50 % and reduced fecundity rate to 5.3 litters per delivery. 
Mortality rate among the new born litters was elevated from 2.8 % in control animals to 31.3 % 
in DEHP treated animals. From observations studies only one rat suffered from tremor. (Table 
3.5). 
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TABLE - 3.5 
EFFECT OF DIBUTYLPHTHALATES (DBP)  &BIS(2-ETHYLHEXYL) PHTHALATES 
(DEHP) ON RATS FEMALE FERTILITY 
          CONTROL          DBP (100 MG/KG)          DEHP (100 MG/KG) 
FEMALES NUMBER:                 15                  9   6  
  
FEMALES COHABITED:                              15   9   6 
PREGNANT FEMALES:             13 / 15              6 / 9   3 / 6  
LITTER: (NEW BORN):                106              44       16 
DIED LITTERS:                  3               23     5 
(percentage lethal cases) 
FERTILITY RATE:                87 %              67 %                  50 % 
(% Pregnant Females / Females Cohabited):   
FECUNDITY  RATE:           8.2 per delivery      7.3 per delivery         5.3 per delivery 
(Average number of litters per delivery): 
OTHER OBSERVATIONS:        - Normal               -  Rotating (1) (10 /min)            - Tremor (1) 
                 Head bending to the right 
            Rearing (1) ( 5 / min) 
 Female rats weighing 120-200gm received twice a week ip injection of DBP and DEHP (100mg/kg). 
Control animals were injected with the same volume with corn oil. Female rats were cohabited with 2 male rats 
for one month. Mortality rate: is the percentage of died litters compared to new born litters. Fertility rate: is the 
percentage of pregnant females per the number of females cohabited. Fecundity rate: is the average number of 
litters per delivery 
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3.2. 2   EFFECT OF PHTHALATES ON TOTAL AND RELATIVE BODY WEIGHT: 
 As total body weight gain is concerned no significant changes were obtained in female 
rats treated with DBP or DEHP compared to control animals (Table 3.6). Similar pattern of 
change in total body weight gain was observed during one month matting or in pre-matting or 
post-matting stage. 
TABLE – 3.6 
CHANGES IN BODY WEIGHT GAIN IN NORMAL RATS COMPARED TO RATS  
TREATED WITH DBP & DEHP 
           CONTROL               DBP(100 mg/kg)           DEHP(100 mg/kg) 
BODY WEIGHT: (gram) 
- INITIAL                                  143.5 ± 5.6 (15) 138.0 ± 7.7 (10)   120.8 ± 3.8 (6) 
(8 days before mating) 
- MATING                  168.6  ± 5.8 (15) 162.3  ±  8.3 (10)     137.3  ±  4.4 (6) 
(1st day)   ↑ 17.5 %  ↑ 17.6 %     ↑ 13.7 % 
 
- MATING                           208.8  ±  8.7 (15) 186.6  ± 5.8 (10)       179.7  ±  5.7 (6) 
(1 months):   ↑ 45.5 %  ↑ 35.2 %      ↑ 48.8 % 
 
- POST  MATING                               217.1  ±  7.5 (11) 203.0  ±  6.3 (6)                       188.3  ±  8.7 (6) 
(After 1 month):                ↑ 51.3 %  ↑ 47.1 %      ↑ 55.9 % 
Values shown are Mean ± SEM for the number of experiments indicated in brackets. Body 
weight was measured one week before mating, the first day of mating, the last day of mating and one 
month after removal of the male rats. Significance of differences between treated and control were 
assessed using Student's t-test. For experimental details see legend of table (3-1) DBP, 
dibutylphthalates. DEHP,  bis (2-ethylhexyl) phthalates. 
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 At the end of the experiments after one month matting and one month after matting 
rats were anaesthetized with ether and the internal organs were removed and weight for the 
measurement of relative weight of the following organs: Heart, kidneys, spleen, liver, brain 
and sex organs. Female sex organs includes: Ovaries, Oviducts, Uterus and Vagina. 
 Relative weight of the kidneys was reduced significantly in DBP treated rats from 
0.685 ± 0.013 (10) gram to 0.638 ± 0.012 (9) gr. (P ≤ 0.05), and the relative weight of sex 
organs was reduced by 27.5 % from 1.787 ± 0.129 (9) to 1.296 ± 0.126 (9) gr. (P 0.05). 
With DEHP treatment no significant changes were observed and the clear reduction of 25.5 % 
in relative weight of sex organs was not significant. 
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TABLE – 3.7 
EFFECT OF DIBUTYLPHTHALATES (DBP)  & BIS(2-ETHYLHEXYL) 
PHTHALATES (DEHP) ON RELATIVE WEIGHT OF BODY ORGANS 
IN FEMALE RATS 
 
          CONTROL                 DBP (100 mg/kg)          DEHP (100 mg/kg) 
HEART:  0.404 ± 0.013 (10) 0.358 ± 0.012 (9) 0.373 ± 0.018 (6) 
 
KIDNEYS:  0.685 ± 0.013 (10) 0.638 ± 0.012 (9)* 0.690 ± 0.038 (6) 
      ↓ 7 %  
SPLEEN:  0.281 ± 0.016 (9) 0.276 ± 0.010 (9) 0.286 ± 0.023 (6) 
 
LIVER:  3.247  ± 0.171 (10) 3.118  ± 0.173 (9) 3.490  ± 0.218 (6) 
 
BRAIN:  0.767 ± 0.023 (10) 0.769 ± 0.026 (9) 0.732 ± 0.036 (6) 
 
SEX  ORGANS: 1.787  ± 0.129 (9) 1.295  ± 0.126 (9)* 1.329  ± 0.160 (6) 
      ↓ 27.5 %  ↓25.6 % NS 
 
Values shown are Mean ± SEM for the number of experiments indicated in brackets. The relative weight 
shows the percentage weight of different organs compared to total body weight in each animal. Three groups of 
female rats treated twice a week with DBP or DEHP 100mg/kg or with the same volume of vehicle solution. Female 
rats were cohabited with male rats for one month as mentioned in table-1 . At the end of experiments rats were 
anaesthetized with ether and the selected organs: heart, kidneys, spleen, liver, brain and sex organs were removed. 
Sex organs included ovaries, oviducts, uterus and vagina. * P ≤ 0.05 
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3.2. 3 BIOCHEMICAL CHANGES IN BLOOD SERUM FOLLOWING TREATMENT 
WITH PHTHALATES: 
 
 The level of biochemical compounds in blood serum of overnight fasted rats was 
measured in control animals and in animals treated with DBP or DEHP.  
 Fig 3.8 shows that Alkaline phosphatase activity was reduced significantly by DBP 
from a control values of 33.85 ± 5.86 (12) to 17.33 ± 3.22 (12) U/L (P ≤ 0.05) and by DEHP to 
18.02 ± 3.24 (6) U/L (P ≤ 0.05).   
GPT values were increased with DBP by 42 %, from 50.33 ± 5.73 (9) to 71.25 ± 2.10 (12) U/L 
(P ≤ 0.02). While GOT values were increased by DBP from 98.38 ± 6.52 (8) to 142.00 ± 11.38 
(10) U / L and with DEHP they were elevated to 181.25 ± 30.80 (6) U/L (P ≤ 0.05). 
 Uric acid was reduced with DBP treatment from its normal values of 1.20 ± 0.12 (12) 
to 0.86 ± 0.06 (12) mg/dl (P ≤ 0.05) and by DEHP treatment to 0.77 ± 0.05 (5) mg/dl (P ≤ 
0.05). Creatinine levels were reduced significantly by DBP from 0.41 ± 0.09 (10) to 0.18 ± 
0.02 (12) mg/dl (P ≤ 0.05). 
 Both phthalates were not able to produce any significant changes with the serum levels 
of glucose, total proteins, triglycerides, cholesterol HDL or cholesterol LDL. 
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TABLE – 3.8 
BIOCHEMICAL CHANGES IN RATS BLOOD SERUM TREATED WITH 
DIBUTYLPHTHALATES (DBP)   
&BIS(2-ETHYLHEXYL)  PHTHALATES (DEHP)  
 
    CONTROL DBP (100 mg/kg) DEHP(100 mg/kg) 
GLUCOSE: (mg/dl)  83.71  ± 8.35  (8) 87.7 ± 4.3 (7)  68.0  ±  5.0 (6) 
ALKALINE PHOSPHATASE: (U/L)33.85 ± 5.86 (12) 17.33 ± 3.22 (12 )* 18.02  ± 3.24  (6)* 
   
GPT: (U/L)   50.33  ±  5.73  (9) 71.25  ± 2.10 (12)** 60.50  ± 12.90 (6) 
GOT: (U/L)   98.38  ± 6.52  (8) 142.00  ± 11.38 (10)* 181.25  ± 30.80 (6)* 
UREA:  (mg/dl)   61.81  ± 5.62 (13) 48.67  ± 4.30 (12) 72.00  ± 6.90 (6) 
CREATININE(mg/dl)  0.41  ± 0.09  (10) 0.18 ±  0.02 (12)* 0.47  ± 0.13 (6) 
URIC ACID: (mg/dl)  1.20 ± 0.12 (12) 0.86  ±  0.06 (12)* 0.77  ± 0.05 (5)* 
TOTAL PROTEIN: (g/dl)  7.19 ± 0.31 (13) 6.54  ± 0.19 (12) 7.74  ± 0.21  (6) 
CHOLESTEROL – TOTAL: 115.97 ± 7.68 (12) 106.70   ± 5.69 (12) 127.60  ± 16.90 (6) 
  (mg/dl) 
CHOLESTEROL- HDL  (mg/dl) 74.05 ± 5.7 (12) 72.23  ± 5.68 (12) 97.10  ± 11.20 (6) 
CHOLESTEROL – LDL  (mg/dl) 22.70 ± 2.73 (12) 18.55  ± 1.72 (12) 19.35  ± 1.30 (6) 
TRIGLYCERIDES: (mg/dl) 62.29  ± 4.70 (8) 58.32  ± 5.68 (10) 68.90  ± 11.00 (6) 
Values shown are Mean ± SEM for the number of experiments indicated in brackets. At the end 
of experiments  blood was collected from the femoral artery of anaesthetized rats, centrifuged and blood 
serum was separated for the measurement of  biochemical compounds. Analysis was performed using 
glucometer for the measurement of blood glucose and Bio-analyzer for measuring all the rest of the 
chemical compounds.* P ≤ 0.05    ** P ≤ 0.02 
3.2.4   FEMALE RATS DNA DAMAGE: 
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Female rats treated with DBP 100 mg / kg has caused oxidative stress and DNA 
damage by increasing 8-OHdG concentration significantly by 29.8 % from 30.63 ± 1.33 (9) to 
39.77 ± 3.30 (6), while DEHP has no effect whatsoever. 
 
FIG. 3.4  
 
 
 
Table 3.9 shows that DBP is more effective in causing oxidative stress in 
female rats more than in chicks embryonic development, while DEHP was more 
effective with the chicks model. 
 
 
TABLE 3.9 
EFFECT OF  DIBUTYLPHTHALATES (DBP)  &BIS(2-ETHYLHEXYL)  PHTHALATES  
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(DEHP) ON DNA DAMAGE IN FEMALE RATS AND DEVELOPING CHICKS 
 
    CONTROL                       DEHP                               DBP 
 
FEMALE RATS:                       30.63±1.33 (9)                     39.77±3.30 (6)            29.20 ±1.43 (6) 
                                                                                                              ↑ 29.8%                          ↓ 4.7 % 
                                                                                                                P ≤ 0.05                           NS 
 
NEW BORN CHICKS:             43.47 ± 6.50 (5)                 54.22±2.87 (3)              60.74±2.02(6) 
                                                                                                        ↑ 14.3%                          ↑ 39.7% 
                                                                                                             NS                                     P ≤ 0.05 
 
Values are Mean ± SEM for the number of experiments indicated in brackets, the 
concentration of 8-hydroxyguanosine (8-OHdG) in blood serum in (ng/ml). DBP and DEHP 100 
mg/ kg were injected intraperitoneally into female rats, and the same concentrations were injected 
in a volume of 60 µl to eggs before incubation. Control samples were treated with the same 
methods of injection and with the same volume of corn oil.  
 
 
 
 
 
CHAPTER FOUR 
 
DISCUSSION 
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Plastics have become an integral part of our everyday lives. Phthalates are plasticizers 
widely used in the manufacture of polyvinylchloride and other plastics, including products, 
clothing, food packing, children’s products and media devices. Thus, the general population 
can be exposed to phthalates in food, water, and air via ingestion or inhalation. Phthalates, in 
general, are colorless, high-boiling liquids, soluble in organic solvents but immiscible in 
water, and they are degraded very slowly in the ambient environment. Diethylhexyl phthalates 
(DEHP), for example, closely resembles organochlorine pesticides (DDT, PCB) in rate of 
uptake and storage. In recent human studies residues of phthalates have been found in milk, 
human tissues and blood plasma. Recent reports on the level of phthalates monoesters 
metabolites in urine samples collected from the third U.S. National Health and Nutrition 
Examination Survey (NHANES Ш) (Bount et al 2000) showed that four metabolites , MEP. 
MEHP, MBP and MBzP were present in more than 75% of subject sampled. The first report 
on human exposure to phthalates in the region, suggests that pregnant women in Jerusalem are 
exposed to a range of phthalates, seven phthalate metabolites were detected in 100% of the 
samples and nine phthalate metabolites were detected in at least 95% of the samples, MEP and 
MBP were found at the highest concentrations, in agreement with findings among pregnant 
women in the United States (Adibi et al 2003; Swan et al 2005) and Taiwan (Huang et al 
2007).  
Therefore, there is scientific and public concern about potential human health risks 
from exposure to phthalates. The Food and Drug Administration and the National Institute of 
Environmental Health Science have a continuing interest and concern regarding the safety of 
phthalates. These concerns stem from studies showing that large populations are exposed to 
phthalates, as well as from animal studies consistently showing that some phthalates are 
developmental and reproductive toxicants. However there is still inconsistency of teratological 
information of phthalates. Therefore, the present study was designed to develop an avian 
model for the neurobehavioral teratogenicity of phthalates. 
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4.1.TERATOGENIC ACTIVITY OF PHTHALATES ON EMBRYONIC DEVELOPMENT:  
As our results (Fig 4.1) showed that embryonic exposure to DEHP 5mg/kg reduced 
hatching rate by 20 % without inducing any defects.  Embryonic exposure to DEHP at higher 
doses of 20-50-100 mg/kg reduced hatching rate by 20 % and induced post-hatch defects in 
dose depending manner. Chicks treated with 100 mg/ kg of DBP has reduced hatching 
percentage to 57% and increased defect chicks percentage by 14 %. Not all phthalates are 
equivalent in the severity of their effect; some phthalates exhibit less or more sever effects. 
The most effective dose of Phthalates in inducing defects characterized as 
Omphalocele, was DEHP 100 mg/kg. Where a single dose injected into the egg before 
incubation has induced birth defects in 22% of the cases. All the defects were characterized as 
Omphalocele with a hole in abdominal muscle, allowing internal organs to protrude externally 
in a translucent sac, while similar dose of DBP has induced birth defects in 14% of the cases, 
and the types of defect was characterized as Gastroschisis where the internal organs protruded 
externally without a sac. 
 
 
 
 
FIG.   4.1 Percentage of Hatching, Late Hatching and Defects on chicks 
exposed to Phthalates 
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Our results demonstrate the usefulness of the chick model for teratogenic evaluation of 
phthalates and provide initial information about two important phthalates members DEHP and 
DBP. In a model that exclude any potential contribution of maternal effects. Three main 
defects; Omphalocele, Gastroschisis and motor disorder, were observed at doses equal to or 
below those found to produce defects in mammalian models, and were never seen in control 
chicks but occurred in doses above 20 mg/kg.  
 
 
An omphalocele is caused by an opening (defect) in the middle of the abdominal wall 
at the bellybutton (umbilicus). The skin, muscle, and fibrous tissue are absent. The intestines 
protrude through the opening and are covered by fine membranes. Some cases of omphalocele 
are believed to be due to an underlying genetic disorder, such as Edward's syndrome or Patau 
Syndrome. Gastroschisis a similar birth defect, but the umbilical cord is not involved, the 
lesion is not usually midline, and not enclosed in a membranous sac.(3) 
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Gastroschisis is an opening in the abdominal wall (muscles and skin of the abdomen) 
that appears during fetal development. The opening occurs almost always to the right of the 
umbilical cord. As a result, the stomach, small and large intestines are not enclosed in the 
abdominal wall and appear outside of the fetus's body, leaving the intestine exposed to 
amniotic fluid, which contains the baby's urine. This contact may irritate the bowel, causing it 
to swell and shorten. Normally, during early development, the intestines, stomach and liver 
protrude to the outside of the body. As the fetus grows, these organs are "pulled in" and the 
abdominal wall forms around them. This does not occur in gastroschisis. As with many birth 
defects, the reason behind it is unknown. Some scientists think that genetics or an 
environmental exposure during pregnancy can cause gastroschisis, but the exact cause is still 
unknown. Unlike other abdominal wall defects such as omphalocele, gastroschisis is typically 
not associated with chromosomal anomalies or other structural malformations. (4) 
Because the chick model unlike mammalian models, dose not involve maternal effects, 
our studies indicate that phthalates evoke neurobehavioral teratogenesis through direct effect 
on developing brain, rather than through indirect compromise of maternal function or 
maternal-neonatal interactions, Furthermore, chicks are more mature at hatching than are 
newborn rats or mice. Cognitive behavior, in the form of imprinting performance, can be 
evaluated immediately.  Prior to any potential impact of prenatal treatment on newborn chick 
tends to follow the first object it sees after hatching  and can thus be imprinted upon an 
artificial object. In this way it becomes a suitable subject for studying the effect of prenatal 
treatment on imprinting behavior (Sluckin W et al. 1972). In the present study we evaluated 
whether DEHP has an adverse effect on imprinting performance in the chick model. 
Preference scores reflect the strength of learning during imprinting (Bateson et al 1966). The 
expected range of the preference score is 0-1. Where 0.5 indicates no imprinting, 1 represent 
maximal imprinting, and 0 represents avoidance (running away from the imprinting object). 
Control chicks showed typical-high imprinting score of about 0.649, chicks exposed to DEHP 
lost their imprinting  ability to 0.509, reflecting adverse impact on the development of the 
hippocampus and the cognitive centers in the brain (McGrath et al. 2004; Yanai et al. 2009). It 
could also be due to its effect in reducing the concentration of PKC isoforms in the left IMHV 
as reported by (Izrael et al. 2004; Slotkin et al. 2005; Slotkin et al. 2008). The neurobehavioral 
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defects could happen with the sub toxic doses of phthalates. The effects on imprinting were 
not secondary to loss of motor function (locomotor activity), since overall activity levels in the 
imprinting apparatus were not significantly affected. 
When measuring the biochemical markers, there was a significant increase in alkaline 
phosphatase by 296% and decrease of urea and creatinine and GOT activity. The elevation of 
alkaline phosphatase is due to a bony pathology or muscular dystrophy this in turn might 
reduce muscle dry mass leading to decrease in creatinine and urea. 
The primary importance of measuring alkaline phosphatase was to check the possibility of 
bone disease or liver disease. Since the mucosal cells that line the bile system of the liver are 
the source of alkaline phosphatase. When the liver, bile ducts or gallbladder system are not 
functioning properly or blocked, this enzyme is not excreted through the bile and alkaline 
phosphatase is released into the blood stream. Thus the serum alkaline phosphatase is a 
measure of the integrity of the hepatobiliary system and the flow of bile into the small 
intestine. In addition to liver, bile duct, or gallbladder dysfunction, an elevated serum alkaline 
phosphatase can be due to rapid growth of bone since it is produced by bone-forming cells 
called osteoblasts (5). The decrease in GPT activity obtained in blood of chicks treated with 
DEHP roles out the possibility of liver damage. The weakness in abdominal muscles and the 
weakness of skeletal muscles and motor disorders indicate muscular dystrophy.  
Previous results using other types of phthalate esters like dibutoxyethyl phthalates, di-
2-methoxyethyl phthalates and octylisodecyl phthalates on developing chicks, has induced 
other congenital malformation such as crania bifida and anophthalmia resulting from an 
absence of bone tissue forming the orbit of the eye and blindness. (Bower et al.1970) 
To study the genotoxicity induced by DEHP and DBP at the molecular level we 
employed DNA Damage ELISA (enzyme-linked immunosorbent assay) it is a fast and 
sensitive competitive immunoassay for the detection and quantitation (8-OHdG), a marker of 
DNA oxidation. Several studies have demonstrated that the 8-OHdG in bodily fluids can act as 
a biomarker of oxidative stress (Takane M et al. 2005), and potentially involved in 
carcenogenesis in various experimental models. 
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Oxidative stress can result in DNA damage, including oxidation of nucleosides. Therefore, 
oxidative DNA damage was assessed in rats and chicks in vivo from serum levels of the DNA 
repair product (8-OHdG). 
Our results indicate that in new born chicks pre exposure to DEHP significantly 
increased levels of 8-OH-dG by 39.7% (P ≤ 0.05), while the 25 % increase induced by DBP 
was not significant. On the other side using female rat fertility model, showed a significant 
increase of 29.8 % (P ≤ 0.05) was achieved on rats treated with DBP (100 mg/kg) while the 
changes induced by DEHP were not significant compared with control group. (8-OHdG) is a 
product of oxidative DNA damage by reactive oxygen species and serves as an established 
marker of oxidative stress. It has been shown to cause G→T and A→C transversions (Cheng 
et al. 1992). Hydroxylation of guanosine occurs in response to both normal metabolic 
processes and a variety of environmental factor. Elevated level of urinary 8-OHdG has been 
detected in patient with various cancers. In human atherosclerotic plaques there were 
increased amounts of urinary 8-OHdG in diabetes correlated with the severity of diabetic 
nephropathy and retinopathy (Wu LL et al. 2004).  In south Indian population, patients with 
essential hypertension a significant increase of urinary 8-OHdG was observed correlated with 
decrease serum TAS levels, which reflect increased oxidative damage (Subash et al.2010). 
The increased levels of 8-OH-dG do not correlate with carcinogenic potency, as similar levels 
of induction have been associated with divergent carcinogenic activities (Marsman et al. 1988, 
1992). Furthermore, DEHP and other peroxisome proliferators have consistently lacked 
initiation activity unlike other DNA-damaging agents. The overall evidence suggests that 
increased production of hydrogen peroxide and DNA oxidation are not solely responsible for 
peroxisome proliferators’-induced liver tumor formation. 
Recent studies reported that DEHP can induce DNA damage in nerve system of mice 
and oxidative damage in internal organs of mice with apparent dose-dependent manner, they 
employed comet assay to measure the DNA damage induced by DEHP in cells of brain 
(Martino-Andrade et al. 2009). Tagaki and coworkers (1992) have examined the possibility of 
DNA damage by DEHP by measuring the induction of (8-OH-dG), in the liver and kidney 
from male rats administered DEHP for various periods of time. Increased levels of 8-OH-dG 
were seen in the liver after 1 or 2 weeks or 12 months of treatment, but no increases were seen 
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in the kidney. In general, the increases were small (2-fold) and in some cases, were not 
sustained with prolonged DEHP treatment (Cattley and Glover 1993).  A study by Duty SM et 
al 2003, represent the first human data to demonstrate that urinary MEP, at environmental 
levels, is associated with increased DNA damage in sperm. 
The reason that serum 8-OHdG was selected as a marker of oxidative DNA damage in 
this study was because of its convenient use in clinical practice and also they allow the assay 
to be non-invasive and it is well known that the study of oxidative DNA damage is clinically 
important. However, no data on serum 8-OHdG in rats and chicks treated with both DEHP and 
DBP are available. 
 
 
 
 
4.2.EFFECT OF PHTHALATES ON FEMALE FERTILITY:  
The present experiments were undertaken to further investigate the action of DEHP 
and DBP upon female rat reproduction. The effects of DBP and DEHP on female rats fertility 
are summarized in Fig 4.2.  
FIG. 4.2: Effect of DEHP and DBP on Female Rats Fertility Rate, Fecundity and 
Mortality Rate 
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The Fertility rate expressed as percentage of  pregnant females per females cohabited. 
was reduced by DBP from 87 % in control rats to 67 % and by DEHP to 50 %. Fecundity rate 
expressed as average number of new born litters per delivery, was reduced from 8.2 per 
delivery in control rats to 7.3 in DBP treated rats and to 5.3 per delivery in DEHP treated 
female rats. Mortality rate was increased significantly by DBP and DEHP from 2.8 % to 52.3 
% and 31.3 % respectively. 
Few studies have investigated the reproductive toxicity of DEHP in female animals. 
The present study coupled with other recently published studies serve to confirm some of the 
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previously reported effects of phthalates on the female reproductive system and the effect of 
DEHP on decreasing fertility rate. Fertility rate was decreased to 50% and 67% by DEHP and 
DBP respectively. In contrast to males, it is generally thought that female reproductive system 
is much less sensitive to phthalates. However, recent evidence suggests that phthalates can 
also induce adverse responses in females following pre and postnatal exposure (Gray et al. 
2006). Initial studies demonstrated that ovary is a target site for DEHP. Davis et al 1994 
reported that high doses of DEHP results in prolonged estrous cycles, reduced serum estradiol 
levels and absence of ovulation in adult rats, which can explain the reduction in pregnancy in 
female rats treated with DBP and DEHP. Fertility studies with crossover mating have also 
shown that active phthalates can decrease the fertility of rats and mice through male and 
female-mediated effects (Lamb et al.1987), which support our results. Shiota et al 1982, has 
reported that mice ingestion of high doses of phthalates caused intrauterine growth retardation 
and delayed ossification with an apparently dose related manner and caused neural tube 
closure in developing embryo.   
In males the first finding of phthalates induced testicular injury in experimental 
animals was reported by Shaffer et al. in 1945. The testicular effects are characterized by 
decreased testis weight and atrophy of seminiferous tubules. The alterations manifested in 
male offspring include cryptorchidism, hypospadias (ectopic opening of the urethra), atrophy 
or agenesis of sex accessory organs, testicular injury, reduced daily sperm production,  
permanent retention of nipple and decreased (feminized) anogenital distance. (Martino-
Andrade et al. 2009). In addition, phthalates induced testicular dysgenesis by affecting sertoli 
cells and leydig cells (Liu et al 2005). 
However, the alteration in spermatogenesis observed after exposure to high doses of 
DEHP could be due to dysfunction in sertoli cells (Kavlock et al. 2002), or through the effect 
of follicle stimulating hormone action on sertoli cells (Lloyd et al. 1988; Heindel and Powell. 
1992), or by targeting leydig cells which induce testosterone (Jones et al. 2004). In general it 
was found that phthalates with medium side chain like DBP or branched long side chain like 
DEHP are more toxic and more effective than those with linear long side chains (Heindel and 
Powell. 1992; Lamb et al. 1987). Furthermore DEHP was found to reduce sperm production 
(Andrade et al. 2006; EFSA 2005). 
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As total body weight gain is concerned no significant changes were obtained in female 
rats treated with DBP or DEHP compared to control animals, these results were consistent 
before mating during one month mating and one month after pregnancy. 
The relative weight of the following internal organs: Heart, kidneys, spleen, liver, and 
brain were not affected following treatment with DBP or DEHP, while the relative weight  of 
the female sex organs which includes: Ovaries, Oviducts, Uterus and Vagina, was reduced 
significantly by 27.5 % in DBP treated rats. The 25% reduction achieved with DEHP was not 
significant. Similar decrease in male sex organs following treatment with Phthalate esters was 
reported by Martino-Andrade et al 2009. 
 
Our results had shown no changes in rat blood glucose level. Previous studies were 
performed to investigate phthalates exposure and its association with abdominal obesity and 
insulin resistance, suggest that exposure to phthalates may contribute to the population burden 
of obesity, insulin resistance and related clinical disorders. (Stahlhut RW et al 2007). In this 
study, when female rats were exposed to DEHP, they were found to have increased serum 
glucose and decreased insulin, as well as thyroid and adreno-cortical dysfunction (Goyathri et 
al 2004). These studies does not support our results, since we have not seen any change in 
glucose levels following treatment with DBP or DEHP in any of the models used, fasted rats 
or non fasted chicks.  From biochemical measurements obtained in this study no significant 
changes were observed in serum levels of glucose, total proteins, triglycerides, cholesterol 
HDL or cholesterol LDL. 
In rats model a significant increase of GOT and GPT activity accompanied with 
decrease in creatinine and uric acid was obtained. This is due to drug related injury to liver 
cells, which increase GOT and GPT and leads to decrease in dry mass which results in low 
creatinine and uric acid. While results obtained from experiments on chicks model there was 
an increase in alkaline phosphatase and a reduction in GPT which is more classical to bony 
muscular dystrophy. 
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Our recent results with DNA damage and all other reports suggests that competitive 
ELISA for 8-OHdG appears to be simple method for quantifying the extent of oxidative stress. 
Several evidence show that oxidative damage may be an important mechanism underlying 
several pathophsiolgical states, for example, atherosclerosis caused by oxidative modification 
of low-density lipoprotein (Ross et al. 1999); diabetic complications caused by oxidative 
damage of lipids, protein (Baynes et al. 1999) and DNA (Dandona et al. 1995); aging caused 
by oxidative damage of proteins and myocardial damage\loss through oxidative injury. These 
results supported with our results that showed oxidative stress is increased upon exposure to 
DEHP and DBP in animal models and could be the mechanism underlying phthalates toxicity. 
 
 
 
 
5.   CONCLUSIONS: 
Nowadays it is well known that phthalates are the most commercially important 
plasticizer for PVC plastics, and one of the serious contaminations in the whole world. DEHP 
is the most distributed phthalate and the greatest potential risk to human health. 
It has reproductive toxicity, developmental toxicity, embryonic toxicity and potential 
carcinogenicity.  
 
Our results show that the medium side chain phthalate (DBP) and the long branched 
side chain (DEHP) are very effective both on chick model and on female rats fertility model. It 
was most effective in inducing teratogenic activity in developing chicks following pre-
exposure to single dose of phthalate (20-100mg\kg), and for the first time it was reported to 
induce Gastroschisis and Omphalocele in new born chicks and in 8-20% of the cases with 
DEHP, these were associated with oxidative stress and DNA damage. Oxidative damage 
induced by DEHP and DBP is an experimental evidence for molecular mechanism of 
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phthalates toxicity.  In addition, it has reduced hatchability and caused neurobehavioral 
deficits as shown in preference scores which reflect the strength of learning during imprinting 
test.  
 
These results indicate that in addition to the effect of phthalates in reducing male 
fertility as reported before, it has reduced female fertility and fecundity and increased 
mortality rate in new born litters. It also showed that phthalates are more toxic when injected 
to early stages of embryonic development, while the effect on adult males or females rats 
needs continues injection of the drug or continuous gestational exposure to very high doses. 
   
The mechanism of action of Phthalates could be due to induction of peroxisome 
proliferation, oxidative stress, or through zinc deficiency. Therefore further experiments are 
needed to elucidate its mechanism of action.  We recommend more epidemiological studies 
using larger human population including (follow-up) studies of infants exposed to phthalates. 
More teratogenic screening experiments should be performed to find the risk of exposure to 
small doses. To avoid even neurobehavioral changes, which affects cognition, learning and 
memory.
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